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Abstract
La Broncopneumopatia Cronica Ostruttiva (BPCO) è un’infiammazione polmonare
progressiva caratterizzata da limitazione di flusso espiratorio. Ad oggi a livello
mondiale si stima che 328 milioni di persone siano affette da BPCO e si prevede che
diventi la quarta causa di morte entro il 2030 con più di 65 milioni di casi l’anno.
Il successo dei trattamenti medici mediante acidi nucleici, come DNA e silencing
interference RNA è fortemente legato al design di efficienti tecnologie di rilascio. I
dendrimeri cationici rappresentano un’interessante possibilità come vettori grazie a
noti vantaggi di efficienza, di basso costo, di produzione e di versatilità d’applicazione
nel trattamento di molteplici malattie e disturbi.
Il presente lavoro di tesi, svolto presso l’Istituto Dalle Molle di Studi sull’Intelligenza
Artificiale di Lugano (CH), ha avuto lo scopo di investigare a livello computazionale
su scala atomica il meccanismo di legame di diversi dendrimeri con un modello di
siRNA, per l’ottenimento di efficienti sistemi di rilascio per il trattamento di BPCO.
In primo luogo sono stati realizzati i modelli di tre dendrimeri con differente fun-
zionalizzazione ed è stato eseguito uno studio preliminare di caratterizzazione in
acqua. In seguito, mediante la dinamica molecolare è stato analizzato il complesso,
esplorandone le caratteristiche di legame in termini energetici e strutturali.
Si è evidenziato come i cambiamenti conformazionali e la presenza di cariche sulla
superficie dei dendrimeri condizionassero il legame con il siRNA.
La diversa funzionalizzazione dei dendrimeri infatti influisce fortemente sulla topolo-
gia e sulle proprietà fisico-chimiche che guidano l’interazione con gli agenti terapeu-
tici e l’ambiente. I risultati di questo lavoro apportano un contributo significativo al
futuro design di vettori di acidi nucleici selettivi, caratterizzati dal miglior compro-
messo tra stabilità del complesso e abilità di rilascio del sistema.
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Chapter 1
Introduction
This chapter introduces the present master thesis research, together with its aims and objec-
tives; It describes some details on the biological background of gene therapy. At the end there
is a summary about the organization of all the chapters treated in this work.
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung
disease usually progressive and associated with an enhanced chronic inflammatory
response in the airways and the lung to noxious particles or gases. Targeting and
silencing the TNF-α gene by siRNA, through engineered dendrimers able to prevent
lung inflammation, is a promising research line for the treatment of COPD pioneered
by the group of Prof. Fattal and Prof. Majoral, France. In multidrug therapeutic
regimen (as in COPD), an easier administration as well as a reduced number of ther-
apeutics and adverse effects, represent a promising strategy to enhance the therapy
success. In this connection, it is well recognized that bioavailability of therapeutic
agents depends on both patients inhalation technique and size of drug-NPs delivered.
In this context, dendrimers size controllability and customizability offer a powerful
property to ensure ad hoc size for different inhalator condition and different patient
features. Finally, it is now accepted that TNF-α system shows several polymorphisms
that can affect the therapy efficacy. Therefore, the ability to specifically silence TNF-α
production in peculiar cells (AMs) could overcome limitations due to population
heterogeneity and reduce adverse effect due to off-targeting (local effect through
mannosylateddendrimer administered by inhalation).
In this work we focus the attention on design and optimize novel dendrimers for
siRNA delivery targeting COPD. In order to model an ad hoc dendrimer-based
system suitable for inhalator purpose and able to guarantee an high TNF-α silenc-
ing, an accurate evaluation of the physicochemical and molecular properties of the
different dendrimers is necessary. In particular our modelling activity will allow to
characterize how different functionalizations may modify dendrimer properties in
term of interaction with cell membrane of the lung tissue.
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Aim of the Thesis
The aim of this thesis is to build advance particle designs for improved deposition and in-
teraction with lung tissue. The main goal is to use computational methods to investigate
the behaviour of different dendrimers in water and in complex with siRNA and to improve
the characterization of the complex during the molecular dynamics simulations. Due to the
particular structures assumed by dendrimers after complexation with siRNA it would be
interesting to study which characteristics it shows,in order to evaluate siRNA-dendrimer
interaction to ensure an appropriate loading and delivery of the therapeutic agent.
The present manuscript is divided in several sections briefly described as following:
• Chapter 1 is the present introductory part.
• Chapter 2 introduces the scientific background concerning the use of gene
therapy for pulmonary disease. In detail, firstly it gives a description of
COPD inflammation and TNF-α receptor. Furthermore, it provides a detailed
description of strategies for gene therapy and the usage of non viral vectors. The
third section is focused on the main role of siRNA in the gene silencing process,
including advantages of siRNA therapy for treatment of lung inflammation.
The use of nanoparticles in siRNA therapy is explained with a special focus on
cationic polymers as dendrimers. Finally, a specific section for the description
of dendrimers structures and properties is dedicated with the attention on
their conformational characteristics in order to improve their efficacy within
the siRNA complex.
• Chapter 3 provides a theoretical overview of the methods used in this work
with particular emphasis on the physical and biophysical aspects. In particular,
the aim of this Chapter is to explore a connection between simulation and
statistical mechanics and describe the theory underlying the present master
thesis work, in order to provide an explanation of the physical background be-
hind computational methods. After a presentation of computational molecular
modelling, a description of Molecular Mechanics and Molecular s approaches
is provided. In the last section an overview is given which covers enhanced
sampling methods.
• Chapter 4 gives a panoramic of three types of functionalized dendrimers
characterization. Particularly it describes a Molecular Dynamics study to
evaluate the behaviour of different generations of three dendrimers, with same
core and branches structure but different terminal groups. In particular, the
role of pyrrolidinium, piperazinium and morpholidinium as terminal group
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will be investigate in order to understand the variations in physicochemical
properties of dendrimer surface.
• Chapter 5 includes a description of the model of siRNA and its complex with
different dendrimers. The chapter presents a molecular modelling strategy
to design optimized dendrimer-based carries for siRNA to be delivered by
inhalation route in COPD treatment. In details, in silico simulations has been
performed to evaluate the siRNA-dendrimer interaction. Classical MD has been
employed to ensure an appropriate siRNA loading and delivery in presence
of different dendrimers functionalized by pyrolidinium, piperazinium and
morpholidinium surface groups.
• Chapter 6 is devoted to general conclusions of this work.
3
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Chapter 2
Use Of Nanoparticles In Gene
Therapy For COPD
This chapter presents an overview of the scientific background underlying thesis work. In
detail, firstly it gives a description of COPD inflammation and TNF-α receptor. Furthermore,
it provides a detailed description of strategies for gene therapy and the usage of non viral
vectors. The third section is focused on the main role of siRNA in the gene silencing process,
including advantages of siRNA therapy for treatment of lung inflammation. The use of
nanoparticles in siRNA therapy is explained with a special focus on cationic polymers as
dendrimers. Finally, a specific section for the description of dendrimers structures and
properties is dedicated with the attention on their conformational characteristics in order to
improve their efficacy within the siRNA complex.
2.1 Chronic Obstructive Pulmonary Disease (COPD)
Chronic obstructive pulmonary disease (COPD), is a collective nomenclature which in-
cludes chronic pulmonary emphysema (CPE) and chronic bronchitis, is a progressive
inflammatory lung disease which is characterized by a persistent airflow limitation, is
usually progressive and associated with an enhanced chronic inflammatory response
in the airways and the lung to noxious particles or gases. It is generally accepted that
cigarette smoking is the most important risk factor for COPD; other factors that can
be contributed to the disease progression are: prolonged and intense exposure to air
pollution, noxious dusts and chemicals [1] (Fig. 2.1).
Inflammatory mediators induce mucus hypersecretion, oedema and inhibition of
tissue repair. These detrimental mechanisms are prompted by smoke, which all
contribute to the respiratory dysfunctions.
This chronic inflammatory response may induce parenchymal tissue destruction (re-
sulting in emphysema) and disrupt normal repair and defense mechanisms (resulting
in small airway fibrosis), leading to the loss of alveolar attachments to the small
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airways and decreases lung elastic recoil. These pathological changes lead to air
trapping and progressive airflow limitation, and in turn to breathlessness and other
characteristic symptoms of COPD. The risk of future exacerbations is estimated by
the severity of airflow limitation and the history of previous exacerbations. COPD is
a leading cause of morbidity and mortality worldwide and results in an economic
and social burden that is both substantial and increasing, an estimated number
of 328 million people have COPD worldwide (168 million men and 160 million
women) [2] with the possibility of becoming the fourth leading cause of death in
the world by 2030 with more than 65 million people dying from COPD every year
[3]. A new approach is necessary to improve therapy efficacy and safety; in fact the
Figure 2.1: Representation of airway disease risk factors. Both asthma and COPD hold pathologic
features belonging to environmental risk factors, sharing outdoor air pollutants and
occupational exposures, and personal risk factors, sharing lung infections, poor nutrition
and low socioeconomic status [4].
treatment of COPD, according to GOLD classification based on symptom and risk
evaluation, includes theophylline, long-acting muscarinic antagonists, long acting
beta-2 agonists (LABAs), LABA/inhaled glucocorticoids (GCs) combinations and the
phosphodiesterase-4 inhibitor roflumilast.
Furthermore, an exhortation to treat COPD with systematic GCs for 7 to 14 days
is included in current guidelines for patients with acute exacerbations, instead of
intermittent systemic corticosteroid use, as a result of the association of the lat-
ter with concomitant adverse effects such as osteoporosis, hyperglycaemia, upper
gastrointestinal haemorrhage, muscle weakness and acute psychosis [5], [6].
2.1.1 Inflammation
The association of airways inflammation and lung pathology in smokers has long
been suspected, moreover many animal model studies and in vitro experiments
have investigated the role of specific inflammatory cells and molecules in COPD
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[7]. Whereas Alveolar Macrophages (AMs) are the predominant cell type found
in airways, they, and to a lesser extent epithelial cells, play a critical role in the
physiopathology of COPD and are a major target for therapy (Fig. 2.2).
AMs extracted from COPD patients have a stimulated secretion of inflammatory pro-
teins, including certain cytokines, chemokines, reactive oxygen species and elastolytic
enzymes[8].
Among those factors, the genetic contribution to the disease has been implicated.
Although the nature of the genetic influences remains undefined, factors that regulate
the inflammatory responses to direct exposure of inhaled insults are important in the
pathogenesis of COPD [9]. In particular, COPD patients show an increased expression
Figure 2.2: Chronic inflammation in COPD is driven initially by cigarette smoking and other inhaled
irritants, which induce a specific pattern of inflammation that predominantly involves the
peripheral airways and lung parenchyma [10].
of Tumor Necrosis Factor (TNF), which has been implicated in several inflammatory
conditions. TNF-α also operates at an early stage in the inflammatory cascade and
plays an important role in many inflammatory diseases of lungs [11].
2.1.2 TNF-alpha
TNF-α is a multifunctional and potent pleiotropic cytokine and is a modulator
of the immune and inflammatory responses; it has been implicated in a variety
of autoimmune diseases, including asthma [9]. Among various proinflammatory
cytokines involved in the pathogenesis of COPD, tumor necrosis factor (TNF)-α plays
a pivotal role in the release of other cytokines and induction of chronic inflammation
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[12]. It has been widely accepted that TNF-α correlates with associated symptoms of
COPD such as weight loss (25% of patients with COPD will develop cachexia) due to
accelerated metabolism and protein turnover [13].
TNF-alpha (TNF-α) exerts a variety of effects, such as growth promotion, growth
inhibition, angiogenesis, cytotoxicity, inflammation, and immunomodulation. It was
hypothesised that TNF-α could be used as a potential effective target for the treatment
of COPD; however, because the multiple effects of this cytokine, it is fundamental to
attack specific processes with a selective approach.
Anti-TNF-α and TNF receptor inhibitors (e.g. infliximab, golimumab and etanercept)
are considered as potential new medications in asthma and COPD management [14],
[15]. However, whereas TNF-α inhibitors are effective in a relatively small subgroup
of patients with severe asthma, they have shown to be ineffective in COPD [11],
[16]. The failure of the above mentioned inhibitors has been related to the TNF-α
polymorphisms associated with clinical features of COPD [17].
2.2 Gene Therapy
In the last two decades the use of nucleic acids as drugs has been claimed to be
an important future direction of molecular medicine. Particularly, nanomedicine
owns many important applications, one of which is gene delivery, which consists in
a powerful approach for the treatment genetic diseases [18] as well as an alternative
method to traditional chemotherapy used in treating cancer.
2.2.1 Strategies
Depending on the type of nucleotide molecule that is used, gene therapy can be
divided into two possible categories: function enhancement (i.e., by using plasmid
DNA (pDNA)) and function inhibition (i.e., by using oligomeric genetic material such
as antisense oligonucleotides (ON), siRNA or DNAzyme), respectively, via different
mechanisms [19].
In general, a delivery system should help to target the therapeutic nucleic acid to the
desired site of action and facilitate efficient intracellular trafficking, typically to the
nucleus [20] (once the complexes have reached the target cells they need to be taken
up efficiently and then processed in the appropriate fashion to allow efficient transfer
from the endosome to the cytoplasm and, finally, the nucleus).
This requires effective traversing of intracellular compartments and the lack of
efficiency for these steps probably represents one of the key limitations of synthetic
gene delivery systems [21].
The use of a vector enables the cellular uptake of the genetic material and protects
against intracellular enzymatic degradation, in fact free oligonucleotides and DNA
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are rapidly degraded by serum nucleases in the blood when injected intravenously
[22]. The attentions of my research are focused on designing effective carrier vectors
that compact and protect oligonucleotides for gene therapy.
2.2.2 Nonviral Gene Delivery
Viral carriers have been used as available vehicles for efficient gene transfer into most
tissues, because they exhibit high efficiency at delivering both DNA and RNA to
numerous cell lines. Nevertheless, there are great problems associated with viral
vector systems, starting from toxicity, immunogenicity, and limitations with respect
to scale-up procedures [23].
Hence, considering the biosafety, drawbacks of viral approach and also costs, the
nonviral vectors for siRNA delivery are increasingly regarded as the best alternatives
to viral ones [24].
Nonviral gene therapy or other nucleic acid therapies have been proposed to treat
more serious diseases which require systemic administration for the gene to enter
the target cells affected by genetic diseases, viral infections or cancer.
Nonviral vectors rely on their ability to bind and to condense genetic material into
such a form that it can navigate through various extra- and intracellular barriers to
the cell nucleus, where genes can be expressed.
2.3 The Role of siRNA
As an alternative to DNA-involved gene transfer, RNAi mediated by small interfering
RNA (siRNA), provides another approach by employing RNA as a powerful tool
that can be used to specifically silence gene expression, and for this reason has been
recognized as a therapeutic agent for the treatment of a variety of diseases, including
viral infections, cancer, and autoimmune disorders [25],[26],[27].
SiRNAs were discovered by showing that the introduction of a long double-stranded
RNA (dsRNA) into a variety of hosts could induce post-transcriptional silencing of
all homologous host genes and/or transgenes [28], [29].
RNA interference (RNAi) is the mechanism adopted by most eukaryotic cells, where
by small double-stranded RNA (dsRNA) molecules control gene expression by potent
degradation of its complementary messenger RNA (mRNA) sequence [22].
2.3.1 Gene Silencing Process
In the general RNAi process, long transcripts of double-stranded RNA (dsRNA) are
cleaved into short 21-25 nucleotide dsRNA, referred to as siRNA by the help of an
endoribonuclease Dicer [24].
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The resulting siRNA molecule is then assembled to a multiprotein complex, the RNA-
induced silencing complex (RISC) to form RISC-siRNA complex in the cytoplasm.
Functional RISC contains four different subunits, including helicase, exonuclease,
endonuclease, and homology-searching domains. After activation, when siRNA
binds to RISC, the duplex siRNA is unwound by helicase, resulting in two single
strands allowing the antisense strand to bind to the targeted RNA molecule (mRNA)
[30]. The endonuclease hydrolyzes the target messenger RNA (mRNA) homologous
at the site where the antisense strand is bound.
Binding of siRNA strand-incorporated RISC to the target mRNA complementary to a
single siRNA strand by base-pairing recognition initiates the cleavage of the mRNA
strand within the target site. This leads to translational repression followed by mRNA
degradation, consequently knocking down the expression of the corresponding
protein and allowing the RISC complex to interact with other molecules from the
mRNA pool for a repetitive action of mRNA degradation [22]. The process is known
Figure 2.3: Representation of the mechanism of RNA interference and gene silencing process [31].
as gene silencing and is highly effective and specific, thanks to the fact that one
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nucleotide mismatch between the target mRNA and the siRNA can prevent the
recognition and thus the silencing process (Fig. 2.3).
2.3.2 Advantages of siRNA Therapy
The ability to repress translation of any disease-causing protein through gene si-
lencing process makes RNAi a potent strategy to tackle disease progression over
conventional therapeutics. Since the discovery of gene silencing by introduction of
doublestranded RNA, RNA interference is widely used in functional genomics and
drug development [28], [32].
Nevertheless, the successful use of this molecule faces challenges for in vivo delivery
[33]. The protection of siRNA from degradation and the promotion of targeted
intracellular delivery for effective knockdown of protein synthesis with minimal
side-effects are the primary requirement for a good and efficient delivery system.
Compared to other RNA molecules causing gene-specific silencing via the RNAi path-
way, as siRNA, shRNA and miRNA, the antisense strand of siRNA is complementary
to the mRNA target and has higher target recognition and binding compared to other
RNA molecules, in which the complementarity with the target mRNA is partial [34].
Design and synthesis of RNAi molecules complementary to any gene are relatively
easy and can be applied using well demonstrated strategies over synthesis of other
small molecule [22].
2.3.3 Drawbacks
Since siRNA can target even mRNAs which their translated proteins are located
inside cells, it has to be delivered into the cytosol of target cells because of its poor
stability in physiological fluids. Thus, the naked siRNA is highly unstable and
rapidly degraded by serum nucleases when administered systemically, furthermore
it induces an immune response and activates circulating mononuclear phagocytosis
as a defense mechanism against viral infection [35].
Moreover, by interfering with other endogenous miRNA pathways siRNA exhibits
off-target gene silencing effects, contrasting siRNA sequences against the same gene
can generate similar gene silencing signatures. Off-target gene silencing occurs when
other mRNA transcripts partially hybridize with the administered siRNA [36].
2.3.4 Targeting and Silencing the TNF-alpha Gene by siRNA
The siRNA therapy is used for treatment of lung inflammation using cationic phos-
phorous dendrimers as transfection agents. Knocking down gene expression using
small interfering RNA (siRNAs) has raised a lot of interest in designing new pathways
for therapeutics. A more selective and effective strategy could be represented by si-
lencing of the TNF-α gene by siRNA. Differently from systemic antibodies/inhibitors,
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siRNA-targeted delivery through inhalation can potentially contain the effect to
specific cells or histological areas such as lung AMs in the case of COPD.
2.4 Nanoparticles for siRNA Delivery
As already mentioned, oligonucleotides cannot cross membranes by passive diffusion
and they are characterized by a very inefficient intracellular delivery [37], therefore,
despite siRNA’s potential strong efficacy, they need to be delivered by nano-systems
which need several key requirements [38], [39], [40]:
• protection from degradation in biological fluids
• increase cellular uptake
• favour subcellular distribution
Thus, the success of gene silencing applications based on the use of synthetic siRNA
critically depends on efficient intracellular delivery. Compared with viral counterparts
and liposomes, nanoparticles-mediated siRNA delivery is a potentially attractive
alternative due to low toxicity and immunogenicity by design, and allow for industrial
production involving good manufacturing practice [41] and amenability to synthetic
modification to incorporate functional elements for targeting and improved delivery,
Fig. 2.4. As a result, a significant amount of research in the past decade has focused
on designing cationic compounds that can form complexes with DNA or RNA and
can avoid both in vitro and in vivo barriers for gene delivery [23].
Figure 2.4: Examples of synthetic vectors. Synthetic gene delivery vectors are based on a number of
different, normally cationic materials which support the packaging of the nucleic acid into
nanoparticles. The most important classes of materials are cationic polymers and cationic
lipids. The lipids are based on self-aggregating small cationic amphiphiles whereas the
cationic polymers form complexes through multivalent electrostatic interactions. [20].
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2.4.1 Cationic Polymers as siRNA Delivery Systems
A key for the successful delivery of siRNA or pDNA in cationic assemblies is the
formation of highly compacted nanostructures generally termed "complexes" that
decrease the hydrophilicity, charge, and size of nucleic acids. The formation of
complexes is mediated by electrostatic interactions between the protonated (positively
charged) amine groups in the carrier backbone and the negatively charged phosphate
groups of the nucleotides [19].
Polycationic branched macromolecules such as dendrimers show a strong binding
affinity for RNA molecules and, hence, can provide an effective, reproducible, and
relatively non-toxic method for transferring siRNAs into animal cells [42]. These
vectors possess cationic nature (e.g., cationic cell penetrating peptides, cationic
polymers, dendrimers, and cationic lipids) and complex siRNA by electrostatic
interaction [43].
Commonly used classes of synthetic vectors are based on various cationic lipids or
polymers and, depending on the synthetic vector material used, the resulting particles
have also been termed lipoplex, polyplex, or dendriplex, when dendrimers are being
used [20].
In general, cationic polymers are advantageous in gene delivery due to their (i)
high stability, (ii) well-defined size and low polydispersity index, and (iii) great
variety of molecular weights, architectures (linear, branched, dendrimeric), and
functional groups. [19]. The design of binding agents devoted creating high-affinity
complexes with nucleic acids is a key point in the development of nanocarriers for
gene therapy and, in particular, the study of their multivalent recognition ability of
strengthening binding is extremely important to generate systems with potential
biomedical applications [44].
2.4.2 Multivalent Ligands
Understanding the factors that influence the interactions between nucleic acids and
vectors is an important prerequisite for their controlled manipulation. A key role
in this phenomenon is played by the multivalency principle, which implies that the
strength of a multivalent binding interaction can be much stronger than the sum of a
corresponding number of monovalent interactions [18].
Multivalency is defined as a type of binding in which multiple ligands are attached
to a single molecular scaffold and used to interact with another entity that displays
multiple binding sites which are complementary to the ligands [45]. For example, the
ionic interaction between a protonated amine and the phosphate backbone of DNA
forms the basis for most synthetic DNA binding molecules used for gene delivery.
However an individual binding unit with one protonated amine cannot efficiently
bind to the phosphate backbone of DNA under physiological conditions, and to
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achieve high-affinity binding, multivalent ligands must be utilized [45], [46].
While the number of binding sites and sizes of the molecules increase, the binding
event also becomes more complex to understand and tune. Polyvalent interactions
therefore give rise to special phenomena such as cooperativity and multivalency, and
the design of such binding systems requires a detailed understanding of the delicate
[47], [48] balance between binding entropy and enthalpy.
The binding of two molecules, both having multiple recognition sites, may occur
with an affinity greater than the sum of the corresponding monovalent interactions,
a phenomenon that has been defined as the "cluster effect". Multivalent binding
between nanoscale objects has recently emerged as one of the most powerful meth-
ods for the assembly of functional supramolecular materials with applications in
nanotechnology.
Multivalent ligands can function as inhibitors or effectors of biological processes.
Potent inhibitory activity can arise from the high functional affinities of multivalent
ligand-receptor interactions. Effector functions, however, are influenced not only by
apparent affinities but also by alternate factors, including the ability of a ligand to
cluster receptors. By altering multivalent ligand architecture, ligands with preferences
for different binding mechanisms would be generated. The structural parameters that
were varied include scaffold shape, size, valency, and density of binding elements,
the architecture of a multivalent ligand is a key parameter in determining its activity
as an inhibitor or effector [47].
2.5 Dendrimers
Dendrimers are globular, synthetic and highly branched macromolecules that have
repetitive structures [49], [50] with a spherical shape that grows in generation. The
Figure 2.5: Schematic structure of dendrimers [51].
name originated from the Greek word Dendron meaning tree and Meros meaning part,
which depicts a structure that consists of a central core molecule that acts as a root,
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from which a number of tree-like arms originates in a symmetrical manner (Fig. 2.5).
2.5.1 Structure and Main Properties
The peculiarity of dendrimers compared to other classical macromolecules is due to
their defined architecture, in particular three distinct characteristics [24]:
1. a central core to define the interior size, the branch number and direction
2. layers of repetitive units (termed generations G) radically attached to the central
core, that also regulate the molecular size and the flexibility;
3. the presence of active terminal groups (and then surface charge) to present the
chemical property and the interaction possibility.
The core of a dendrimer is denoted as generation zero, in the Fig. 2.6 is shown how
the valency of the core determines the starting number of branching points.
Indeed, their structure grows regularly with the generation dendrimers with high
generation numbers having a high density of primary amine groups on the surface
which make them efficient for binding nucleic acid molecules. An increase in the
generation number affects the shape of a dendrimer. Dendrimers of lower genera-
tions have a planar or elliptical shape, whereas dendrimers of higher generations
typically have a spherical structure with a hydrophobic interior core, useful for the
encapsulation of bioactive molecules [52]. Thus, higher generations present not only
a higher electrostatic potential to attract oppositely charged target molecules but also
a higher level of backfolding and surface crowding [53].
The possibility to carefully increase the number of "branched layer" (generation) and
therefore to finely tune surface properties and the structure flexibility, represents a re-
markable feature of this family of nano tools [54]. Reactive end-groups of dendrimers
Figure 2.6: Representation of dendrimers of generations 1 to 4. The n denotes number of terminal
functional groups [22].
allow the addition of repetitive units or branching in a controllable manner and
versatility by modification of the end groups for multiple copies of various ligands
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including therapeutics and imaging agents for biomedical applications [55].
Moreover the ordered structure is characterized by strong symmetry and periodicity
and the surface can be functionalized in many ways to modulate the physicochemical
properties of the final construct [56], [57].
Thanks to the high degree of versatility and a very large number of potential applica-
tions, dendrimers are emerging as a new class of structure with outstanding features
for nanomedicine [58].
Branched macromolecules, dendrimers and dendrons, are not afflicted by problems
of polydispersity. Indeed, such molecules can be considered to constitute a unique
nanoscale construction kit, with each generation of growth modifying the size of the
building block. In addition, dendrons can display a high density of functional surface
groups that can offer multiple simultaneous interactions. This leads to enhanced
binding - the multivalent effect, which is correlated with the dendritic generation and
constitutes an additional advantage of dendritic polymers over their linear analogues
[46]. With regards to this, in the last study particular attention has been given to these
characteristics of the terminal groups, in connection with the multivalency effect that
is the most important property recognized [59], [60].
2.5.2 Dendrimers as Delivery Vectors
Thanks to their multivalent structure and due to the fact that the success of medical
treatment with DNA and siRNA is strongly related with the design of efficient
delivery technologies, dendrimers offer considerable advantages in binding nucleic
acid [61], for this reason in the last decade their structures has been proposed as ideal
candidates to deliver and release genetic material inside cells [23], [62], [20], [63].
The low-cost and adjustable controlled release DNA delivery systems have important
advantages over other DNA delivery methods, including DNA protection before
release, site-specific delivery using implantable polymers, and long-term release
without repeat administration [64].
The properties such a high ratio of multivalent surface moieties to molecular volume
make dendrimers highly interesting for the development of synthetic (non-viral)
vectors for therapeutic nucleic acids [20].
2.5.3 Dendrimers as siRNA Delivery Vectors
Among versatile non-viral vectors, dendrimer-based siRNA carriers have been grad-
ually explored since their performance in DNA delivery was approved (Fig. 2.7).
There are basically three means to optimize the dendrimer structure for lowering the
cytotoxicity as well as improving the delivering efficiency [24]:
1. synthesis of new dendritic structure or the use of new core unit for dendrimer
preparation;
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2. functionalization of the interior or exterior part of dendrimer molecules;
3. employing other biocompatible/bioactive molecules to form effective complexes
with dendrimers.
In particular, polycationic dendrimers represent a promising strategy for delivering
siRNA in lung [18].
The positively charged primary amine groups on the surface of these dendrimers
allows electrostatic interaction with negatively charged siRNA molecules [22].
However, in order to design an ad hoc dendrimer-based system suitable for in-
halational purposes and be able to guarantee high TNF-alfa silencing, an accurate
evaluation of the physicochemical and molecular properties of the different den-
drimers is necessary.
After lung administration, nanoparticles (NPs) should be internalized by alveolar
macrophages (AMs). To further increase the cellular pool of NPs their surface may be
functionalized by dendrimers to specifically bind the C-type lectin receptor on AMs
membrane and reduce side effects [65], [66], [67].
Figure 2.7: The proposed mechanism of dendrimer mediated siRNA delivery and gene silencing. [New
J. Chem. 2012; 36:256-63] - adapted by [31].
2.5.4 Surface Modification for Improved Efficacy with siRNA
Surface functionalization of nanocarriers with a wide variety of polymers and target-
ing ligands is a promising approach to achieve specific functions [68].
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As said previously, the multivalent recognition of DNA and siRNA by dendrimers is
strictly related to their structural flexibility, in terms of the ability to orient and use
their surface charges in a cooperative way [69], accordingly the descriptor of "flexible"
behaviour is refered to local structure and do not necessarily communicate global
structure of dendrimers.
Thus the multivalent polycationic surface is able to generate multiple strong ionic
interactions with the charged phosphate groups of nucleic acids [69] and this is the
reason of such high affinity toward DNA and siRNA. Furthermore, the structural
modifications of dendritic generations due to binding with nucleic acids indicate the
ability to adapt to a charged target.
Comparing different generations of dendrimer their number of charged surface
groups grows exponentially with higher generation, so that the global attraction
with nucleic acids grows too. Moreover, the study of the multivalent behaviour of
these molecules takes into account that not all of these charged groups are actively
participating in the binding, this because the multivalent binding action of multiple
surface groups cannot be explained as a simple attraction (it is a balance between the
amount of charge and ability to use these charges efficiently) but it is related to the
molecular flexibility. There is a limit in the advantage that is possible to obtain simply
by adding charged groups to the structure. This depends on the surface density and
makes the difference in treating dendrimers as flexible molecules rather than as rigid
spheres [42].
To utilize dendrimers for energetically favorable binding interactions, they should be
designed in such a way that the number of binding interactions is maximized while
internal strain in the bound molecules is minimized [70].
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Chapter 3
Materials And Methods
The aim of this Chapter is to explore a connection between simulation and statistical mechanics
and describe the theory underlying the present master thesis work, in order to provide an
explanation of the physical background behind computational methods. After a presentation
of computational molecular modelling, a description of Molecular Mechanics and Molecular
Dynamics approaches is provided. In the last section an overview is given which covers
enhanced sampling methods.
3.1 Computational Molecular Modeling
Modeling the behaviour of physical systems with mathematical equations has been
one of the main aims of scientists, since the beginning of modern science. A model
is a powerful tool, which allows to predict with a certain degree of confidence the
results of an experiment or the consequences of an event without having to materially
reproduce such experiment/event.
Computational molecular modeling is an excellent tool which scientists use to visual-
ize molecules. The tool represents molecular structures numerically, and simulates
the atomic and molecular interactions that govern microscopic and macroscopic
behaviours of physical systems with the equations of quantum and classical physics;
it includes all theoretical methods and computational techniques used to describe
complex biophysical systems in terms of a realistic atomistic description, aimed at
understanding and predicting their macroscopic properties.
These properties are not found analytically because of the large number of molecules
that generally constitute molecular systems, the problem being solved through nu-
merical methods, which thanks to their low-scale level of description are able to
discover the features of the case study and to create a point connection between
laboratory experiments and theory.
The most accurate techniques can be considered the quantum mechanics/molecular
mechanics methods (QM/MM), whose aim is to solve the wavefunction of a system
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using the Born-Oppenheimer approximation. This approximation breaks the wave-
function into two separated terms, namely an electronic one and a nucleic one [71].
QM/MM methods can describe the evolution of a molecular system in a very accurate
way, however, because of their similar accuracy, such methods are inadequate to
simulate systems which are larger than about hundred atoms, hence not very useful
for characterizing biological complexes.
At an upper level (spatial scale of nanometer and time scale of nanosecond), Molecu-
lar Dynamics and Montecarlo simulations are powerful tools of investigation: indeed,
these two methods are the ones that are most used in biomolecular modeling, because
they are the ones that best cover the temporal and spatial scales that are involved in
processes of particular interest, for example, protein folding [72].
In particular, Molecular Dynamics (MD), solving Newton’s second law represents a
powerful multidisciplinary method at the nanoscale level based on physics, chemistry,
statistical and molecular mechanics and it is applied in fields such as material science,
computational chemistry, drug design and computational biology to understand the
structure and the dynamics of proteins, protein folding and unfolding, multi-scale
modelling, molecular docking and receptor-ligand interaction, transport and diffusion
properties of molecules.
3.2 Molecular Mechanics
Differently from quantum mechanical methods, which is based on Schrödinger
equation and deals with the electronic motions in the system and examines structures
as a function of electron distribution, the Molecular Mechanics (MM) method uses
Newtonian mechanics to model molecular systems, analysing the system as a set of
atoms interacting through a potential energy function.
The most important theoretical bases of MM are founded on the important results
produced by analytical mechanics. The core of the MM approach is the set of the
equations and parameters used to describe the potential energy function V of a
molecular system, also known as force field.
Several force-fields are available for molecular simulations. The choice of the force-
field strongly depends on the system which has to be simulated and also on the
simulated conditions (e.g., explicit/implicit water, ions, etc.). Among the most
commonly used potential energy functions are the AMBER, CHARMM, GROMOS
and OPLS/AMBER force fields.
3.2.1 Potential Energy Function
Atom interactions are taken into account in terms of potential energies, from which
information about the forces is extracted. Potential energy is a multidimensional
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function which depends on the spatial coordinates ri of all the N atoms that constitute
the system. It is the sum of two different contributions, which are a function of the
coordinates ri of all the N atoms in the system:
E(rN) = EB(r
N) + ENB(r
N) (3.1)
where EB is the sum of all the functional expressions describing the bond interactions
among the atoms in the system and ENB is the sum of the functional expressions
describing the nonbond interactions in terms of Van der Waals and electrostatic
contributions. The two terms in equation (1) can be expressed as:
EB(r
N) = Ebonds(r
N) + Eangles(r
N) + Edihedrals(r
N) (3.2)
ENB(r
N) = ECoulomb(r
N) + EVdW(r
N) (3.3)
The potential energy function can be described as:
V(rN) =
1
2
kij[rij − r0,ij]
2 +
1
2
ξijk(cos(θijk)− cos(θ0ijk))
2
+ φijkl
(
1 + cos
(
nφijkl − φ0ijkl
))
+ 4ǫij
[
(
σij
rij
)12
−
(
σij
rij
)6
]
+
qiqj
4πǫ0ǫrr0
(3.4)
where the first three terms in the sum represent the bond interactions, while the last
two represent the non-bond interactions.
3.2.2 Treatment of bond and non-bond interactions
In equation 4 there are several terms that can be distinguished in bond and non-bond
interactions. In particular, the mathematical term that describes the interaction due
to the covalent bond is:
Ebond =
1
2
kij[rij − r0,ij]
2 (3.5)
The variable is rij and the other two parameters (kij, r0,ij) that appear in the equation
have a well-defined physical meaning. kij represents the bond stiffness, while r0,ij
is the equilibrium distance, and depends on the atom types that are bonded. This
association of atomic bond interactions with an equation that resembles a simple
elastic spring was discovered to be a very good (as well as computationally cheap)
approximation.
The angle bond contribution includes all interactions among the three atoms (repre-
sented by indices i, j and k), that are covalently bound together. The potential energy
is expressed as a function of the angle θijk, formed by the three atoms, the equilibrium
angle, θ0,ijk, and the stiffness, ξijk, of the bond angle:
Eangle =
1
2
ξijk(cos(θijk − cos(θ0ijk))
2 (3.6)
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The dihedral bond interactions, that are usually called proper dihedral interactions,
involve four atoms (i, j, k, and l), that are covalently bound one after the other one.
Edihedral = φijkl [1 + cos(nφijkl − φ0ijkl)] (3.7)
The potential energy is described as a function whose variables are the stiffness of
the dihedral angle, ξijlk, the dihedral angle φijkl between vectors that are normal to
the planes that are identified by the atoms i, j, and l, and atoms j, k and l respectively,
and the equilibrium dihedral angle, named φ0,ijkl .
The last two terms of Eq. 4 belong to the group of non-bonded interactions. There
are a number of non-bonded interactions that act in nature. However but just the two
main ones are usually included into the force fields, and they are the Van der Waals
and Coulomb energies.
The Coulomb energy, ECoul , takes into account the electrostatic interactions between
charged particles, while the Lennard-Jones energy, ELJ , accounts for a combination of
excluded volume effects and Van der Waals interactions. Coulomb interactions are
active between any two charged particles (also just partially charged), i and j in the
equation. The strength of the interaction depends on the quantity of the charges, qi
and qj, as well as the relative distance rij among them.
ECoul =
qiqj
4πǫ0ǫrr0
(3.8)
The energy depends on the distance between the particles rij, which implies that the
Coulomb interaction is a long-range one.
Alternatively, the Lennard-Jones energy describes two kinds of forces that work
combined on two different distance-ranges:
ELJ = 4ǫij[(
σij
rij
)12 − (
σij
rij
)6] (3.9)
The first term represents the very short-range repulsion due to overlapping by electron
orbitals. The second one describes the long-distance Van der Waals attraction energy.
The two fixed parameters, σij and ǫij, depend on the atom types and specifically
indicate, respectively, the shortest distance for which the Lennard-Jones energy is
zero and the depth of the potential well. The calculation of non bond-forces is
extremely complicated in terms of computational effort, because the number of the
non-bond interactions increases as the square of the number of atoms in the system.
To properly reduce the computational effort, the non-bond interactions are computed
by applying the distance cutoff. With the application of the cutoff distance, every
interaction between two atoms is computed only if their distance is smaller than the
cutoff chosen. In Fig. 3.1 the summary of interaction terms in a typical biomolecular
Force Field is reported, as described in the paragraph.
22
Figure 3.1: Summary of interaction terms in a typical biomolecular Force Field [73].
3.2.3 Periodic Boundary Conditions
In the computational models often used are the Periodic Boundary Conditions (PBC),
in order to circumvent the natural finite size of the simulation box, the edge effects.
All the atoms are put in a space-filling box, usually filled with water (implicitly or
explicitly modelled), surrounded by translated copies of itself as shown in Fig. 3.2,
with the aim of removing boundaries of the system. Thus, when a dynamic step
pushes a particle out through one side of the simulation box, with PBC the particle
is re-positioned on the opposite side. Moreover, in order to avoid self-interactions
with periodic copies, the simulation box and the interaction cutoff distance has to be
comparable. The inaccuracies resulting from the presence of PBC are expected to be
less severe than the errors resulting from an artificial boundary with vacuum. In the
minimum image convention, which states that with periodic boundary conditions
cut-off distance should be small enough to avoid a particle seeing itself in the adjacent
box, each individual particle in the simulation interacts with the closest image of
the remaining particles in the system, which is repeated infinitely if PBC are settled
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on. Applying a cutoff distance is not a problem for short range interactions as the
Lennard-Jones potential which decreases very rapidly, but the long-range interaction
model requires the use of more accurate methods (e.g., shift function, and switch
functions) with the aim of avoiding discontinuities in the potential energy calculation.
Figure 3.2: This figure represents the periodic boundary conditions. The central box, with the
molecules of interest in red and the water in blue, is replicated in copies of itself.
3.2.4 Potential Energy Minimization
The Potential Energy function is a complex multidimensional function of molec-
ular system coordinates. Minimum points of the Potential Energy Surface (PES)
correspond to local stable states of the system. Any movement away from this config-
uration, is characterized by higher energy. The minimum with the lowest energy is
known as global minimum. The process of energy minimization is able to reduce
the potential energy of the system. To identify the minimum point of the PES there
are two different approaches to the minimization problem: derivative methods and
non-derivative methods.
Energy minimization is widely present in a molecular dynamics simulation, especially
for simulation of complex system, such as macromolecules.
3.3 Molecular Dynamics
Molecular Dynamics (MD) is a technique that solves the Newton’s equations of
motion for a system constituted by interacting atoms. The main principle consists of
establishing the temporal evolution of the atomic positions. For this, the system is
modeled as a mass set of atoms or molecules. This is a deterministic method, which
means that the future state of the system is completely determined by its present
state.
24
Employing Newton’s equation implies the use of classical mechanics to describe the
motion of the atoms:
mi
d2ri
dt2
= Fi (3.10)
with i = 1, 2,..., N. The force Fi is the vectorial sum of all the forces that act on the ith
particle of the system: these forces are all derived from a function V(rN) that includes
and describes how all the particles interact each other. This function is the called
potential energy function, and it is related to the force Fi of the previous equation
through
V(rN) = −∇Fi (3.11)
The equations of motion are solved by integrating the above equations using small
time steps, whose order of magnitude is usually between 1 and 10 fs.
This means that during the simulation, at every time step, the position and the
velocity of every single atom in the system are calculated. At each step, the initial
positions and velocities of all the atoms in the molecular system need to be known
and these are the input data. The forces alternatively are calculated through the
potential energy. While the positions are usually accessible from the crystallographic
structures that are present in some apposite databases (like for example PDB Data
Bank), the velocities are almost never known, so they need to be assigned, at least
for the first iteration. This can be done using a Maxwell-Boltzmann distribution at
a specific temperature, for example 300 K, that is the temperature that is normally
used for biological systems.
As indicated, the initial configuration of the molecular system usually comes from
experimental data, especially crystallographic structures. These experimental tech-
niques usually bring to data that represent systems is very far from the equilibrium.
Thus an energy minimization is required to be performed before running MD simu-
lations. From a practical point of view, what is done is to reduce interaction forces
among atoms that are excessively large, i.e. to relax the system.
The MD approach uses conservative force-fields as "constitutive laws" for the sim-
ulated systems which are function of the atomic positions only. This implies that
the electronic motions are not considered. However electrons are supposed to adjust
their dynamics instantly following the atomic position, as the Born-Oppenheimer
approximation demands. A force-field is a set of parameters which specifies the func-
tional expressions describing interactions among atoms. The force-field parameters
take into account all the static properties of the system, e.g. covalent bond constants,
whereas the atom positions or velocities describe the dynamics of the system. In
particular, the force-field parameters represent the constants of the functional expres-
sions describing all bond and non-bond interactions among atoms.
Several force-fields are available for molecular simulations: the choice of the force-
field strongly depends on the system which has to be simulated and also on the
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simulated conditions (e.g., explicit/implicit water, ions, etc.).
3.4 Statistical Ensembles
There is a strong connection between computer simulations of biochemical systems
and Statistical Mechanics. Simulations give microscopical properties (e.g. atomic
positions and velocities), and the equivalent of experimental measurements are
represented by statistical averages over microscopical configurations.
To compute the macroscopic properties it is necessary to generate a representative
statistical ensemble, which defines all the accessible physical states of a molecular
system.
The identification of the appropriate statistical ensemble and the issue of ergodicity are
the main points in the computer simulations. In particular, the physical characteristics
of a system are translated in weighting prescriptions for the points (q, p) of the phase
space D × R3N of N-particles system
r ≡ (r1, ..., rN) ∈ D ⊂ R3N
p ≡ (p1, ..., pN) ∈ R3N
}
⇒ (r, p) ∈ D × R3N (3.12)
Within a statistical ensemble, given an observable A(r, p), the calculation of the mean
value 〈A〉 is expressed as the statistical average
〈A(r, p)〉 =
∫
D × R3N A(r, p)µ(drdp) (3.13)
where µ(drdp) = ρ(r, p)drdp is a probability measure and ρ(r, p) indicates the proba-
bility density.
The points (r, p) represent the accessible microstates for the system, thus µ(drdp)
represents relevant thermodynamic macrostates that the system could exhibit.
The practical computation of ensemble averages requires one to sample a set of
configurations (rn, pn)n=1,...,M from the probability measure µ(drdp) ("trajectory" in
the phase space). After sampling, the approximation
〈A(r, p)〉µ ≃
1
M
M
∑
n=1
A(rn, pn) (3.14)
estimates the mean value of a given observable A.
Following the identification of the correct thermodynamic ensemble, the simulation
is able to perform the requested sampling. The actual interpretation for times ∆t
between sampled points and for the total duration of the sampling τ = M∆t depends
upon the specific simulation choices, and the M number of sampled points. This is
connected to the ergodicity. In fact the ergodicity condition is fulfilled when almost all
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the phase space is sampled, within the interval τ. Consequently, with a time average
approximation the Eq. 14 becomes
〈A(t)〉τ =
1
τ
τ
∫
0
A(r(t), p(t))dt (3.15)
as if we are following the solution (r(t), p(t)) of some kind of equations of motion in
phase space. The ergodic hypothesis assumes that the time averages of Eq. (2.5) on
very long trajectories and the ensemble averages of Eq. (2.2) converges (at least in the
thermodynamic limit). To make use of this hypothesis, the interval τ has then to be
sufficiently long to ensure that almost all the phase space is explored.
The equilibrium is defined by an ensemble of states, and while the low-energy states
are more probable that high-energy ones, the latter will also appear in the ensemble
due to thermal fluctuations, with a probability given by the Maxwell-Boltzmann
distribution. At equilibrium, the instantaneous temperature of the system evolved
around the target temperature T. Most natural phenomena exhibit a wide range of
characteristic time scales.
In a MD simulation the integration time-step has to be commensurate with the
fastest internal dynamics (typically △t ∼ 1 fs). This sets a limit to the available total
simulated time and, consequently, to the ability of a simulation to reproduce some
classes of events. There are, indeed, phenomena that happen at time scales several
order of magnitude larger than the integration time scale.
Similarly, systems which are characterized by rare events or systems that exhibits
metastabilities (in which thermodynamical wells are separated by very high, non-
thermal free energy barriers) highly suffer for the time scale separation. Systems
which exhibit the above features are non-ergodic in practice from the simulation
point of view.
3.4.1 Implementation scheme
In Fig. 3.3 is presented the MD implementation scheme, where the initial positions
and velocities are provided as input data. Starting from the atomic positions ri,
the potential energy V is calculated and models the interaction between atoms; the
scheme continues with the calculation of the forces Fi acting on each atom, by deriving
the potential energy function. Where upon the integration of the equation of motion
leads to the calculation of new position ri and velocities vi.
The cycle goes on for a number of steps until the equilibrium and the convergence of
the computed equilibrium property are reached. Finally, using the output trajectory
of the MD, the macroscopic thermodynamic properties (e.g., temperature, energy,
pressure) can be calculated as time averages.
27
Figure 3.3: Implementation scheme of Molecular Dynamics, in which the initial positions and veloci-
ties are provided as input data.
3.5 Enhanced Sampling Methods
When the thermodynamic equilibrium properties are based on free energies (e.g.
binding constant, solubility, relative stability of molecular conformation, etc.), classical
MD is not sufficient and is limited by two important causes:
• high computational costs, due to the large number of interacting atoms, which
can reach the number of hundreds of thousands or even millions, leading to
an incorrect estimation of the macroscopic thermodynamic property under
investigation;
• rough energy landscapes, with many local minima frequently separated by
high-energy barriers, causing the system being trapped in a relative free en-
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ergy minimum, impeding thermal fluctuations which might never be able to
overcome the energy barriers.
To solve the problem, a vast variety of methods has been developed. Some aim to
reduce the number of degrees of freedom of the problem, some others to enhance
the sampling resorting to non-Boltzmann probability weight factor simulations. A
solution is constituted by the coupling of classical MD with more complicated
sampling techniques, e.g. replica exchange MD, metadynamics, umbrella sampling
which allow the system conformation to escape from energy wells.
3.6 Metadynamics
Metadynamics is a non-equilibrium molecular dynamics method which accelerates
the sampling of the multidimensional free energy surfaces by adding an external bias
potential as a function of the collective variables [74]. The bias potential discourages
the system from revisiting previous sampled region and allows one to surmount
energy barriers. Consider a N-particles system, interacting with the potential V(r), and
Figure 3.4: View of metastable systems. The barrier crossing is a stochastic event because the order of
magnitude of the free energy barrier is much higher than the thermal energy kBT. The
wells indicated as A and B are then metastable states.
evolving under the action of a dynamics having a canonical equilibrium distribution at
a temperature T. For system wherein the dynamics is stuck in some local minimum of
V(r), the escape probability is very low (Fig. 3.4). The idea of metadynamics is to add
a history-dependent potential to bias the system not to return to previously visited
points in the configurational space [75]. In basic implementations of metadynamics
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at time t the bias potential is:
VG(S, t) =
∫ t
0
dt′wexp(−
d
∑
i=1
(Si(R)− Si(R(t
′)))2
2σ2i
) (3.16)
where S is a set of d functions of the microscopic coordinates R of the system; ω is
an energy rate and σi is the width of the Gaussian. The energy rate (w) is constant
and usually expressed in terms of a Gaussian height W and a deposition length τG
(ω = W/τG). Metadynamics shows the advantage of accelerating the sampling of
rare events by pushing the system away from local free-energy minima and exploring
new reaction pathways as the system tends to escape the minima passing through
the lowest free-energy saddle point. Furthermore the bias potential VG provides an
unbiased estimate of the underlying free:
VG(S, t −→ ∞) = −F(S) + C (3.17)
in which C is an additive constant and the free energy F(S) is defined as
F(S) = −
1
β
ln(
∫
dRδ(S − S(R))exp−βU(R)) (3.18)
with β = 1kBT and U(R) is the potential energy function.
3.6.1 The choice of Collective Variables (CV)
The relevant dynamics of the system will be encoded in a suitable formed reaction
coordinate, called ξ(r). Equivalently, the CV retains all the information about the
relevant changes in the system (the slow or rare event) without taking into account all
the microscopic details of the dynamics of the system. To this extent, an appropriate
definition for a CV set should satisfy two properties: a) to clearly distinguish between
different states of the system and b) to describe all the slow degrees of freedom related
to the process of interest. In particular, if the wrong reaction coordinate is chosen, or if
an important collective variable is neglected, then a strong bias in the reconstruction
is introduced. Thus, the biased dynamics could be affected by hysteresis effects
leading to a wrong evaluation of the free energy landscape. A possible check to
evaluate the quality of a chosen CV is to investigate whether the metadynamics
along that coordinate is able to sample ergodically the reduced space. Given these
indications, every possible function ξ(r) of the spatial coordinates is eligible to be
a reaction coordinate. For example, geometry related variables (distances, angles,
dihedrals, gyration radius, ...) or interaction variables (potential energy, coordination
number, hydrogen bonds, ...) could be addressed for metadynamics. An operative
scheme for a simulation may be the following:
1. run a standard MD simulation to monitor the evolution of the selected reaction
coordinate ξ(r). This is useful to establish the characteristic size of the variation
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of the variables in unbiased condition, that is the size of the smallest feature of
interest in the free energy landscape;
2. guess the parameter (σ, τG, ω) for the algorithm to work;
3. start metadynamics and during the run, collect the deposited Gaussians for
further free energy estimate;
4. monitor the explored positions in order to evaluate the diffusivity in the CV
space and stop the reconstruction at time t’.
During the run, the bias potential will in time fill all the minima of the free energy
landscape. The bias itself (the sum of all deposited Gaussians) will be the estimate
of the free energy for a sufficient long simulation time. After this simulation time,
the dynamics of the reaction coordinates will be nearly diffusive or, equivalently,
the probability density of the biased system becomes nearly uniform. The slow
deposition argument does not give a real proof of convergence of the bias potential
to the free energy density function. However, it is clear that the filling process is
able at least to give an estimation that oscillates around the real free energy function
F(z). An estimate of the error of metadynamics is possible by means of averaging
processes that benefit from this oscillation around the real value.
Two principal drawbacks are present in metadynamics technique: firstly, the free
energy estimation does not converge to a definite value but fluctuates around the
correct result and this creates a large difficult to understand when the simulation has
to stop, secondly the problem is that the selection of CVs has an high impact on the
correct estimation of the free energy.
3.6.2 Umbrella Sampling
A fundamental thermodynamic equation that describes the free energy for the
formation of a biological complex (i.e. protein-ligand) relates free energy to changes
in enthalpy and entropy:
∆G = ∆H − T∆S (3.19)
where ∆G is the difference in Gibbs free energy of the binding reaction, and represent
changes in enthalpy and entropy, respectively, and T is the temperature of the system.
It is useful to know how the free energy changes as a function of reaction coordinates.
Here it is useful to introduce the concept of the potential of mean force (PMF) [76],
that for a system with N atoms describes an average force over all the configurations
of all the n + 1...N atoms acting on a atoms j at any fixed configuration.
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Weighted Histogram Analysis Method (WHAM)
A common technique used to calculate the Potential of Mean Force (PMF) along a
given reaction coordinate is Umbrella Sampling (US) (Fig. 3.5). PMF is a type of
experiment done in molecular dynamic simulations which computes how a system’s
energy changes as a function of some specific reaction coordinate parameters. The
umbrella sampling is designed to overcome limited sampling at energetically unfavor-
able configurations by restraining the simulation system with an additional, usually
harmonic, potential:
wi(ξ) =
1
2
Ki(ξ − xii)
2 (3.20)
Then, a series of separate umbrella simulations are conducted with this potential;
these simulations restrain the system at position ξi(i = 1, ..., Nw) with a force constant
Ki. Umbrella histograms hi(ξ) are recorded from each Nw umbrella simulation, and
are called umbrella windows; they represent the probability distributions Pi(ξ) along
the reaction coordinate biased by the umbrella potential. The most commonly used
method to unbiased the distribution Pi(ξ) and compute the PMF from histograms
is the weighted histogram analysis method (WHAM) [77]. Since the free energy is
the change in PMF of a system along the reaction coordinate, WHAM estimates the
statistical uncertainty of the unbiased probability distribution given the umbrella
histogram followed by calculating the PMF with the smallest uncertainty.
Figure 3.5: Schematic representation of Umbrella Sampling method, for an example of protein-ligand
interaction: protein (red circle) and ligand (blue circle). Along the reaction coordinate
(protein-ligand distance) independent simulations are run with additional harmonic
potential where ligand is restrained by its centre of mass. Each window provides with
the probability of finding (histogram) according to the harmonic potential. Overlapping
windows provide the input to weighted distribution analysis method which provides the
Potential of Mean Force (PMF) (the free energy along the distance) of protein-ligand
interactions [78].
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Chapter 4
Investigation Of Dendrimers By
Molecular Dynamics
This chapter describes a Molecular Dynamics study to evaluate the behaviour of different
generations of three dendrimers, with same core and branches structure but different terminal
groups. In particular, the role of pyrolidinium, piperazinium and morpholidinium as terminal
group will be investigate in order to understand the variations in physicochemical properties
of dendrimer surface.
4.1 Introduction
The development of different dendrimers has biological and biomedical applications
and is a promising alternative to synthetic polymers frequently used in drug delivery,
as demonstrated by several theoretical and mathematical modelling. In fact, with
advantages as low cost, ease of production, well-defined size and a good complexation
with siRNA, dendrimers represent an attractive strategy to serve as drug carriers.
Dendrimers show high versatility for application in the treatment of different diseases.
Generally, the properties of therapeutics-loaded dendrimers directly depend on
physicochemical, molecular and supramolecular characteristics. Moreover, a central
point of all multivalent ligands is the important for biomedical applications of their
multiple copies of binding units organized on a single scaffold [79].
Several recent studies have explored the poly(amidoamine) PAMAM dendrimers
performance and the influence of structure of dendrimers on their properties [80],
[81], [82], [83] and also five critical nanoscale design parameters were proposed by
Tomalia (size, shape, surface chemistry, flexibility and architecture) [84].
In detail, glycodendrimers (such as mannose-functionalized dendrimers) have been
described as promising tools due to the high biocompatibility degree [85]. An
interesting property compared to other NPs is the potentiality to be customized
in order to obtain either proinflammatory properties [86], or anti-inflammatory
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features (e.g. mannose dendrimers) [87], [88], and thus for example preventing lung
inflammation [65]. The structure of dendrimers in solution has been shown to be
independent of concentration, unlike the linear polymer analogues [89].
In connection with siRNA delivery, fourth generation cationic phosphorus-containing
dendrimers have been demonstrated to be good candidates for drug and gene delivery
carriers after experiments in vivo [66] and they have shown to be effective in silencing
TNF-α. Particularly, here the analysis will be focused on the role of pyrolidinium,
piperazinium and morpholidinium as terminal group of the dendrimers, will be
evaluated in order to understand which are the physicochemical and mechanical
properties which may drive the experimentally identified effectiveness of specific
dendrimer functionalization strategies.
In fact, dendrimer functionalizations strongly affect the topology and the physico-
chemical properties of them, driving the interaction with therapeutic agents and
the environment. Accordingly, conformational organization and assembly among
components of dendrimers are still under investigation.
4.2 Materials and Methods
Three models of functionalized dendrimers have been developed in relation to
atomistic coordinates and force-field parameters, using classical General Amber Force
Field (GAFF).
The structures and properties of different dendrimers has been investigate using a
computational approach based on classical Molecular Dynamics (MD), in terms of
study of different conformational characteristics (i.e. core, generation and terminal
groups) and physico-chemical characterization.
4.2.1 Model Development of Functionalized Dendrimers
The 3D models of three different dendrimers were developed starting from the stoi-
chiometry and the knowledge about the physical and chemical properties of related
atoms and bonds. All dendrimers are composed by a series of residues, starting from
the first generation to four: a central core, a repetitive branch unit and a terminal
surface group; with the growth of generation, a repetitive branch unit is added, as
shown in Fig. 4.1.
The characteristic that differentiates the three functionalized dendrimers is the pres-
ence of specific terminal groups, which determines dendrimer properties among with
surface charge, hydrophilic and hydrophobic area, ability of binding.
In particular, dendrimer terminal are constituted of pyrolidinium (in 16/CEF/051
dendrimer, here labeled DP); morpholinium (in 16/CEF/294 dendrimer, here labeled
DM) and piperidinium (in mk016 dendrimer, here labeled DG).
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The schemes of Fig. 4.2 show distinct structures for all the terminal groups, however
all present positively charged nitrogen, an important factor that causes a not neutral
total charge for the dendrimers.
Figure 4.1: Example of dendrimers considered for the proposed research, in figure are represented
only dendrimers with pyrolidinium as the terminal group (16/CEF/051), also are shown
different generations from one to four (corresponding to 1-4 of the scheme).
Figure 4.2: Three different dendrimer terminal groups used in this work.
After the building of the dendrimers structures partial charges were calculated
considering separate residues by the RESP fitting method at the HF/6-31G level of
theory using Gaussian09 on the RED server [90]; in this way a proper distribution of
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the partial charges is obtained, which correctly takes into account the conformation
of dendrimer and related bonds. Then, the topology and the parametrization were
developed using leap module of AMBER 16. In the Table 4.1 below are schematized
the characteristic of three dendrimers under investigation as a function of the four
generations considered, in terms of total charge and number of atoms ascertained in
different dendrimers.
16/CEF/051 16/CEF/294 mk016
generation charge number of atoms number of atoms number of atoms
G1 12 396 408 432
G2 24 912 936 984
G3 48 1944 1992 2088
G4 96 4088 4104 4296
Table 4.1: Scheme of the characteristics of dendrimers simulated in this project. All the systems were
solvated in a water box in presence of 150 mM NaCl concentration.
4.2.2 Molecular Dynamics Simulations
Molecular Dynamics provides a molecular level picture of structure and dynamics,
here MD simulations were performed using Gromacs-5 program [78]; the force field
parameters for the atom types were obtained using the antechamber module [91].
The systems were solvated in a TIP3P water octahedron box and an appropriate
number of ions (Cl- and Na+) was added to neutralize them using the leap module
of AMBER 16 . Subsequently, after an energy minimization of 5000 steps of steepest
descent energy, the system was equilibrated for 200 ps at 300 K and 1 atm (under
NVT and NPT conditions, respectively) and finally 100 ns of classical molecular
dynamics simulation was performed until stability is reached.
All these simulations were run under periodic boundary conditions (PBC) applied
along the xyz coordinates and the equations of motion were integrated with a 2.0 fs
time step, where the bonds constrained were treated with LINCS algorithm [92].
In order to characterize the energetic behaviour of the system and to study its stability,
different properties were followed along the simulation, first at all those coming from
characteristics of functional groups and different surface charge of dendrimers.
4.2.3 Analysis
During the course of simulations, with the aim of controlling the stability of den-
drimers conformations obtained from modeling, some analysis have been performed,
in particular the evolution in time of important parameters as Root-Mean-Square De-
36
viation (RMSD), Radius of Gyration Rg and Solvent Accessible Surface Area (SASA)
is reported.
The Radius of Gyration (Rg) is a fundamental tool for the description of structural
properties of dendrimers. This quantity represents the average distance between
each atom in the structure considered and the center of mass of the dendrimer, as
indicated by the eq. 1
R2g =
1
N
N
∑
k=1
(rk − rmean)
2 (4.1)
and it takes into account the spatial distribution of the atom chain by mediating over
all N molecular components [42].
Thus, Rg is a good indication of the shape of the molecule at each time: if a dendrimer
is rigid, it will maintain a relatively steady value of radius of gyration over the
simulation, differently, if is flexible, its Rg will change over time.
Another performed analysis was the evaluation of time evolution of Total Solvent
Accessible Surface Area (SASA) for all the generations of three dendrimers under
investigation. The extent to which a macromolecule interacts with its environment,
the solvent, is naturally proportional to the degree to which it is exposed to these
environment. The solvent-accessible surface area (SASA) is a geometric measure of
this exposure, and therefore a dependency exists between SASA and environment
free energy.
Cluster Analysis
With the aim of finding and studying the equilibrium conformations of three den-
drimers, cluster analysis was performed. Using an unsupervised classification al-
gorithm, clustering, structures that are similar to each other within a certain RMSD
threshold are grouped together. The size of a cluster, the number of structures that
belong to it, is also an indication of how favourable that particular region of the
conformational landscape is in terms of free energy. In particular, GROMACS-5
implements an algorithm in the cluster program; here, we use the gromos clustering
algorithm with a cutoff of 2.5 angstroms.
Briefly, the algorithm first calculates how many frames are within the threshold of
each particular frame, based on the RMSD matrix, and then selects the frame with the
largest number of neighbours to form the first cluster. These structures are removed
from the pool of available frames, and the calculation proceeds iteratively, until the
next largest group is smaller than a pre-defined number. Importantly, it also gave
a PDB file with the centroid representative of the cluster. Furthermore, partition
generated by clustering has been validated by visual inspection of the structures
returned as cluster centers.
For the visual examination of the simulated systems it was employed the Visual
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Molecular Dynamics (VMD) package [93]; using VMD tools the charge distribution
difference are visible, showing how dendrimers stand in presents of a different
number of residues and different terminal groups.
Equilibrium Quantitative Analysis of Dendrimers
Dendrimers flexibility was evaluated on a residue basis using the root mean square
fluctuation (RMSF) of the positions of the center of mass for different repetitive units.
The RMSF measures its deviation from the time-averaged position during the simula-
tion:
RMSF(i) =
√
< r2i > − < ri >
2 (4.2)
where ri is the coordinate vector for atom i and the <> indicates a time-averaging.
In general, calculation of the Root Mean Square Fluctuations (RMSF) is a measure-
ment of the thermal motions of different residues. It captures, for each residue, the
fluctuation about its average position, consequently, Root Mean Square Fluctuation
(RMSF) curve is a good indicator for their fluctuation (and therefore for dendrimers
fluctuation), consequently residues corresponding to higher values of generation
express more flexibility during simulation.
Another evaluation was made on the Radial Distribution Function (RDF) to un-
derstand how the chlorine (negative ions) present in the solvent are positioned at
equilibrium in reference to charged positively amines. Specifically, the charged
amines arranged on terminal groups has been selected and taken as reference for
the calculation of RDF. The Radial Distribution Function (RDF) or pair correlation
function gAB(r) between particles of type A and B is defined as:
gAB(r) =
< ρB(r) >
< ρB >local
=
1
< ρB >local
1
NA
NA
∑
i∈A
NB
∑
j∈B
δ(rij − r)
4πr2
(4.3)
with < ρB(r) > the particle density of type B at a distance r around particles A, and
< ρB >local the particle density of type B averaged over all spheres around particles
A with radius rmax, usually half of the box length.
4.2.4 Adaptive Poisson-Boltzmann Solver Method
The average-linkage method implemented in the gmx cluster tool of the GROMACS-5
was used to perform cluster analysis, with aim to find the most populated cluster and
use it as input for electrostatic calculation with APBS-method [94]. In the average-
linkage method, the cluster similarity is assessed by computing the mean distance
between members of each cluster, where the distance between structures is given
by the Root Mean Square Deviation (RMSD) of the atomic positions after optimal
superposition. Each system snapshot was considered as part of a cluster when its
distance to any element of the cluster was less than a critical threshold.
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Adaptive Poisson-Boltzmann Solver (APBS) is a software package designed to es-
timate the electrostatic interactions in the dendrimers, solving the equations of
continuum electrostatics. The Poisson-Boltzmann (PB) equation is a non linear elliptic
partial differential equation which is solved for the electrostatic potential, starting
from Poisson’s equation:
−∇ǫ(x)∇ϕ(x) = ρ(x) (4.4)
the basic equation for describing the electrostatic potential ϕ(x) generated by a
charge distribution ρ(x) in a continuum model of a polarizable solvent with dielectric
constant ǫ(x).
4.3 Results
4.3.1 Conformational Stability of Dendrimers
To evaluate the structural stability of MD simulations it was used the Root Mean
Square Deviation (RMSD) as an indicator of convergence of the structure towards
an equilibrium state; the gromacs program is used to examine the variation the
RMSD from the original structure of the dendrimer as a function of time during the
simulation. The RMSD plots (Fig. 4.3) show oscillating profiles with high deviations
in the first 25 ns of simulation, then the profiles get stabilized and reach a constant
behaviour as the simulation time progressed. In general, the value of RMSD increases
with generation and reaches a stable value more rapidly in case of 16/CEF/051 and
16/CEF/294 dendrimers. In all cases a flat plot of RMSD value after the first 30 ns
of simulation ensures that the system has reached stability. Also the time evolution
of total Radius of Gyration (Rg) for all generations of three dendrimers is plotted,
showing the stability of system reached after a little reorganization of the structures
(Fig. 4.4).
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Figure 4.3: Time evolution of total Root-Mean-Square Deviation (RMSD) for all generations of three
dendrimers: 16/CEF/051 (a); 16/CEF/294 (b); mk016 (c).
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Figure 4.4: Time evolution of total Radius of Gyration (Rg) for all generations of three dendrimers:
16/CEF/051 (a); 16/CEF/294 (b); mk016 (c).
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Figure 4.5: Time evolution of total Solvent Accessible Surface Area (SASA) for all generations of
three dendrimers: 16/CEF/051 (a); 16/CEF/294 (b); mk016 (c).
Another important data is the time evolution of surface area; in detail, high SASA
values represent a system that provide weaker environmental protection; here SASA
values are plotted over the total simulation time of each dendrimer (Fig. 4.5).
4.3.2 Equilibrium Dendrimers Configurations
A comparison between equilibrium configurations in vacuum and in water is pre-
sented as a good indicator of how structures in solvent goes to a significant confor-
mational reorganization, collapsing into a globular shape and drastically reducing
the space taken.
The phenomenon is more accentuated for higher generations that undergo a strong
reduction in water (Fig. 4.6-4.8). Otherwise, all dendrimers equilibrated in vacuum
maintain a perfectly spherical and orderly shape, with terminal groups which form
the outside of the sphere and with several space among different branches accessible
to solvent.
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Figure 4.6: Comparison of 16/CEF/051 dendrimers configuration after equilibration in vacuum
(left) and in water (right): G1 (a); G2 (b); G3 (c); G4 (d).
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Figure 4.7: Comparison of 16/CEF/294 dendrimers configuration after equilibration in vacuum
(left) and in water (right): G1 (a); G2 (b); G3 (c); G4 (d).
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Figure 4.8: Comparison of mk016 dendrimers configuration after equilibration in vacuum (left) and
in water (right): G1 (a); G2 (b); G3 (c); G4 (d).
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The configurations obtained from cluster analysis have been used as reference for
the equilibrium analysis of dendrimers. Then, equilibrium conformational energetic
properties investigation of all three dendrimers was performed.
From the equilibrated phase of MD trajectories has been evaluated the distributions
of Radius of Gyration, histogram below shows for all of the dendrimers the average
values with relative standard deviations.
From profiles of time evolution of the radius of gyration is visible that Rg grows
with generations and all dendrimers of G1 presents flat Rg plots for an average value
around 1 nm that is almost identical to the value observed for the starting structure
and consistent with a rigid framework. For all second generation structures is visible
a little arrangement in the first 10 ns of simulation after which they get rapidly to a
Rg around 2.45 nm.
In contrast, with the growing of generations dendrimers reorganize by collapsing
from an initial, extended structure to a compact equilibrated globule corresponding
to a significant reduction in radius of gyration (Fig. 4.9).
About that, dendrimers of third generation present a visible conformational reorgani-
zation, in particular for 16/CEF/051, whose Rg goes from 2.4 nm at the beginning of
simulation to 1.8 nm after 20 ns beyond which remains almost stable; Rg of mk016
shows variations up to 60 ns of simulation when reaches a flat trend around 1.9 nm;
otherwise 16/CEF/051 dendrimer quickly achieves a stable value of 1.9 nm without
meaningful variations. Finally, for all G4 dendrimers it is highlighted a prominent
reorganization over time starting from a value around 3.1 nm to 2.4 nm of Rg.
Figure 4.9: Histograms of average values and standard deviation of equilibrium distribution of Radius
of Gyration for 16/CEF/051, 16/CEF/294 and mk016 dendrimers (labelled: DP , DM
and DG, respectively), comparing four different generations.
Also for the Solvent Accessible Surface Area (SASA) it was calculated the distri-
bution at equilibrium, in particular, are distinguished hydrophobic and hydrophilic
components. The histograms below (Fig. 4.10) shows the results obtained as average
values and relative standard deviation at equilibrium; the reference values of Total
SASA are reported in Table 2.
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As seen for Rg, this significant conformational reorganization for high generation
is reflected also in the SASA plots where the effect is more pronounced for third
and fourth generations. In details, for dendrimers of second generation the Solvent
Accessible Surface Area starts from a value around 85 (95 nm for 16/CEF/051) to 65
nm2 after 25 ns of simulation. Otherwise, for 16/CEF/051 and mk016 dendrimers
of G4 generation the Solvent Accessible Surface Area starts from a value of 350 to
250 nm2, with 16/CEF/051 and 16/CEF/294 that reach a flat plot after 20 ns of
simulation and mk016 that manifests reorganization until 40 ns, it reflects a more
flexible structure in higher generations compared to G1.
Figure 4.10: Histograms of average values and standard deviation of equilibrium distribution of SASA
components (hydrophobic in red and hydrophilic in blue) for all dendrimers, comparing
four different generations.
Another interesting analysis is about the different components of Solvent Accessi-
ble Surface Area, here plays a significant role the different composition of atoms in
terminal groups of three dendrimers (4.2).
Firstly, it’s immediately evident that there are no significant differences between the
results of the four generations of dendrimers because for each dendrimer the value
are similar, furthermore in accordance with the specific conformation and the number
of atoms SASA exhibits an increase in value with generation.
Commensurate with the atoms disposition in dendrimers, in SASA histogram is
visible that the most exposed sites are hydrophobic (around 88% of total value, with
an higher value of 89 % for mk016 dendrimer), compared to 12 % of hydrophilic
component.
Also, it is very interesting to note the difference made by the presence of oxygen
in the terminal groups of 16/CEF/294 dendrimers (in morpholinium); indeed it
presents a notable value of hydrophilic component of around 18 %, considerably
higher than others. Its notable to observe that the Solvent Accessible Surface Area
calculated only for the core of dendrimers shows a flat trend around 2.2 nm2 during
the simulation, that indicates no significant variations of the core surface exposed
over time.
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Hydrophobic (%) Hydrophilic (%) Total SASA (nm2)
16/CEF/051-G1 88.9 ± 8.9 11.1 ± 2.2 31.1
16/CEF/051-G2 88.5 ± 4.0 11.5 ± 1.4 59.0
16/CEF/051-G3 88.7 ± 4.9 11.3 ± 1.6 120.3
16/CEF/051-G4 88.2 ± 2.4 11.7 ± 0.6 120.3
16/CEF/294-G1 81.9 ± 6.3 18.1 ± 2.9 29.8
16/CEF/294-G2 81.5 ± 6.1 18.5 ± 2.4 63.3
16/CEF/294-G3 82.8 ± 2.1 17.2 ± 0.7 122.6
16/CEF/294-G4 82.5 ± 1.6 17.5 ± 0.5 237.5
mk016-G1 89.6 ± 7.9 10.4 ± 2.9 31.8
mk016-G2 87.9 ± 5.9 12.1 ± 2.0 64.4
mk016-G3 89.1 ± 2.4 10.9 ± 0.6 126.9
mk016-G4 89.1 ± 6.3 10.9 ± 1.1 261.6
Table 4.2: Solvent Accessible Surface Area components as a percentage of total (average value and
standard deviation); in the last column are reported the Total SASA values.
Therefore, it’s useful to study the trend of the fluctuations of different residue of
dendrimers to understand the movement and the flexibility of each one. In particular,
it has been calculated thanks to the Root Mean Square Fluctuations (RMSF) measure-
ment, that captures the variations about average positions.
From the plots in Fig. 4.11 (where is represented the average value of RMSF for
every repetitive branching unit) is evident that the value of RMSF increases with the
number of generation, but also is visible that all of the external branches presents an
higher value of RMSF (as shows figures of G1-dendrimers).
For G1-dendrimers, 16/CEF/051 exhibits the highest values of RMSF for terminal
groups (0.61 nm); in all plots is visible that the core (AAA) doesn’t present any
fluctuation that reflects its rigid structure.
Finally, a very important aspect of analysis consists in the study of Radial Distribution
Function of Cl ions around charged amines of terminal groups.
This analysis allows to establish the dendrimer’s ability to attract negative ions (Cl),
which depends mainly on generation and hence on the number of loaded amines
present in the macromolecule terminal units.
RDF plots (reported in Fig. 4.12) the average density of Cl atoms at specific distance
(coordinate r) relative to the amine of dendrimer at each simulation step.
It is worth noting that high peaks in a certain zone of these graphs correspond to
areas of high atomic density and low atomic mobility.
The non-uniformity in peak height in the RDF profile suggests a difference in the
ability of the two regions to readily vibrate.
An important result is the presence of a high peak in a specific distance from amines
that correspond to the area of high atomic density and also low atomic mobility. That
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is, the Cl center of mass shows an area of high atomic density at 0.5 nm from amines
after which falls off rapidly for higher distances.
The curve for all generation is picked at this value and it takes into accounts the
interaction distance between two charged atoms. It also indicates that a large part of
the Cl takes part in the interaction.
Furthermore, RDF plots correctly exhibit an interesting dependence on dendrimer
generation, and therefore dendrimer size. Infact, the number of ions considerably
grows with generation and high ones exhibit low surface and very high energy.
(a) (b)
(c) (d)
Figure 4.11: Equilibrium Root-Mean-Square Fluctuation (RMSF) calculated in function of different
residues for all dendrimers: G1 (a); G2 (b); G3 (c); G4 (d).
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Figure 4.12: Equilibrium Radial Distribution Function (RDF) of ions (Cl) in reference to amines
of the terminal groups for three dendrimers: 16/CEF/051 (a), 16/CEF/294 (b) and
mk016 (c), different four generations are comparised.
Equilibrium Evaluation of Charges Effect
Below are reported the equilibrium configurations, corresponding to the cluster’s
arrangement, for every dendrimers, put side by side with the map of relative elec-
trostatics interactions founded using Adaptive Poisson-Boltzmann Solver (APBS)
method. The VMD molecular graphics software package provides support for both
the execution of APBS and the visualization of the resulting electrostatic potentials
(the "Color Scale Data Range" was fixed to -10 to 10), the results are reported in Fig
4.13-4.15. The principal feature of APBS images is the overall positive electrostatic
potential of the dendrimers, which will plays a significant role in the interaction with
siRNA. In the color scale the negative net charges are colored red, while the positive
net charges blue.
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(a)
(b)
(c)
(d)
Figure 4.13: Equilibrium configuration of 16/CEF/051 dendrimers (left) and map of electrostatics
interactions (right) founded using Adaptive Poisson-Boltzmann Solver (APBS) method:
G1 (a); G2 (b); G3 (c); G4 (d).
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(a)
(b)
(c)
(d)
Figure 4.14: Equilibrium configuration of 16/CEF/294 dendrimers (left) and map of electrostatics
interactions (right) founded using Adaptive Poisson-Boltzmann Solver (APBS) method:
G1 (a); G2 (b); G3 (c); G4 (d).
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(a)
(b)
(c)
(d)
Figure 4.15: Equilibrium configuration of mk016 dendrimers (left) and map of electrostatics interac-
tions (right) founded using Adaptive Poisson-Boltzmann Solver (APBS) method: G1 (a);
G2 (b); G3 (c); G4 (d).
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4.4 Discussion
In this work, the structural-physico-chemical profiles have been presented for 3
different functionalized dendrimers for gene therapy, which in this specific case could
be applied in the treatment of lung inflammations.
Generally, in appropriate MD simulation, a suitable force field is important for the
correct structural and dynamic predication and mechanism explanation. Here the
chosen force field (GAFF) has been successfully applied for our dendrimers.
From the analysis it follows that the size, shape, effective charge and terminal charac-
teristics of dendrimers, play significant role in their application as delivery vectors.
Primarily, the conformational stability analysis for all three dendrimers under in-
vestigation highlights different behaviours between the generations in terms of
conformational arrangement and variation during the simulation time.
The related results show that the ability of dendrimers to change their structural
conformation is strongly dependent on the generation, with a proportional relation.
From data it proves that all dendrimers structures undergo considerable structural
changes in presence of solvent compared to vacuum, with a collapse that reduces its
whole occupation area. The phenomenon is more pronounced in the case of higher
generations (G3, G4). Thus, it leads to different binding characteristics between
generations because of different structures obtained.
Furthermore, it has been demonstrated that with the growing of generation the struc-
ture of macromolecules changes; on one hand, the lower generations exhibit flexible
conformations, on the other hand, G3 and mostly G4 show more rigid and compact
conformations. In higher generation dendrimers the numerous branching terminal
units create a kind of cover around internal ones, keeping inside the hydrophobic
parts of dendrimer. DM dendrimers are the ones who exhibit the higher hydrophilic
component (with higher percentage of SASA values reported).
Correctly, the analysis of Radial Distribution Function of Cl ions around charged
amines of dendrimers terminal groups highlights the capacity to attract negative
ions (Cl) present in the solvent, as a function of dendrimer generation and therefore
dendrimer size. Indeed, the number of ions considerably grows with generation and
high ones exhibit low surface and very high energy. From data results the presence
of high peak for all generations in a specific distance from amines that correspond to
the area of high atomic density and also low atomic mobility; it takes into accounts
the interaction distance between two charged atoms and indicates that a large part of
the Cl takes part in the interaction.
Moreover, from APBS analysis emerges that the existence of many charged terminals
conducts G3-G4 dendrimers to be surrounded by a positive potential, which may
allow the formation of multivalent interactions with nucleic acid; differently, lower
generation dendrimers may neutralize the siRNA electrostatic surface in the binding
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region. As a consequence, the binding with siRNA might show different features,
comparing different generations and dendrimers.
4.5 Conclusion
Here we wanted to compare three different types of dendrimers (DP, DM and DG) in
order to study their structural and electrostatic characteristics.
These MD simulations provide significant informations about the design of dendrimer
size, shape, or surface properties for applications in nanomedicine, as in the treatment
of lung inflammation with gene therapy.
The development of highly-efficient and low-toxicity macromolecules as good carriers
will allow advances in understanding of interactions involved in the gene deliver
process.
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Chapter 5
Characterization Of
Dendrimer-siRNA Complexes
This chapter presents a molecular modelling strategy to design optimized dendrimer-based
carries for siRNA to be delivered by inhalation route in COPD treatment. In details, in silico
simulations have been performed to evaluate the siRNA-dendrimer interaction. Classical
MD has been employed to ensure an appropriate siRNA loading and delivery in presence
of different dendrimers functionalized by pyrolidinium, piperazinium and morpholidinium
surface groups.
5.1 Introduction
The design of efficient delivery technologies is an important key for a successfully
medical treatment with silencing interference RNA (siRNA). The advantages of
siRNA therapy for treatment of lung inflammation as COPD have been established.
In addition, the use of nanoparticles as carriers in siRNA therapy, with a special focus
on cationic polymers and dendrimers, has been proven in several research studies
[20],[18],[22].
For example, the main characteristics of PAMAM and PEI dendrimers for efficient
siRNA deliveries and potent gene silencing have been widely exposed in recent times
[95], [83], [62], [81], [96]. In the last years several approaches have been promoted to
achieve this goal.
Generally, dendrimer functionalization modifies the interaction properties in particu-
lar for what concern the ability of binding siRNA molecules. In details, mechanical
properties of dendrimers, such as surface properties, in terms of charge distribution
may affect the free energy of interaction which lately drives the siRNA delivery in
loco.
A good delivery technology should guarantee the release from the endosomal path-
way (endosomal escape). The negatively charged nucleic acids are generally not
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able to spontaneously cross the likewise negatively charged cell membranes to reach
the cytoplasm or cell nucleus on their own, however, may be ingested by the endo-
/lysosomal pathway.
Recent studies have demonstrated that rigid polycationic dendrimers are able to
reorganize their peripheral groups to generate a large number of contacts with the
nucleic acid [80]. They found that flexible dendrimers, originally conceived to create
multivalent interactions with nucleic acids, generate only few contacts, revealing the
role of molecular flexibility in the binding phenomenon. The efficacy of PAMAM
dendrimers and PEI polymers has been demonstrated to strongly depend on its struc-
ture, molecular mass and charge density; however, significant cytotoxicity strongly
limits its application [83].
Therefore, the above mentioned siRNA-dendrimer based nanocarrier seems to be
a promising strategy to increase siRNA concentrations in AMs, reducing dose and
ensuring biocompatibility. However, in order to design an ad hoc dendrimer-based
system suitable for inhalator purpose and able to guarantee a high TNF-alfa silenc-
ing, an accurate evaluation of the physicochemical and molecular properties of the
different dendrimers in complex with the nucleic acid is necessary.
In this context molecular modelling helps to better understand mechanism of binding
and delivery by a specific analysis with atomic resolution, it proves to be a powerful
strategy in nanocarrier characterization of physical-chemical properties and mech-
anism of action. Evaluation of siRNA-dendrimer interaction at the atomistic level
has been employed to ensure an appropriate loading and delivery of the therapeutic
agent. At present three types of dendrimer, called 16/CEF/051, 16/CEF/294 and
mk016, of three different generations have been investigated for gene delivery.
This work provides results that will be used for future design of selective nucleic acids
carriers characterized by a good complexation stability and ability of the delivery
system.
5.2 Materials and Methods
Molecular Dynamics simulations have been performed with the aim of evaluating
the siRNA-Dendrimer interaction. In particular, three siRNA-dendrimer complexes
have been developed in presence of different functionalization.
Whereas in the previous Chapter three types of dendrimer have been analysed in the
unbound condition, here we intend to investigate the complexation with siRNA in
order to evaluate how the macromolecules are capable of an internal reorganization
due binding. Enhanced sampling techniques such as Umbrella Sampling can be
applied to improve the sampling efficiency of classical MD, allowing the estimation
of the siRNA-dendrimer adsorption free energy.
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5.2.1 RNA Structure Model
Starting from the stoichiometry and the knowledge about the physical and chemical
properties of related atoms and bonds a 3D model of siRNA has been developed.
This specific siRNA sequence is composed by a sense strand:
5′ − pGUCUCAGCCUCUUCUCAUUCCUGct − 3′ (5.1)
and by an antisense strand:
5′ − AGCAGGAAUGAGAAGAGGCUGAGACAU − 3′ (5.2)
where the lower case letters indicate 2’-deoxyribonucleotides, underlined capital letters
represent 2’-O-methylribonucleotides and p is a phosphate residue. The model consists
of 50 nucleotides and it has been selected as a siRNA model for the present work. The
relative starting coordinates were built to be in the canonical B-form of the AMBER
NAB tool and its structure is presented in figure below.
5.2.2 Building of siRNA-dendrimer Complex Mode
With the purpose of building a complex, together with the structure of nucleic acid,
the models of three different polycationic dendrimers were built (Fig. 5.1, right). They
consist of several repeating units and are differentiated by their terminal groups, as
widely described in Chapter 3.
Here, for convenience, those dendrimers are labelled as follows:
1. dendrimer 16/CEF/051, which is labelled DP, has pyrolidinium terminal group
2. dendrimer 16/CEF/294, which is labelled DM, has morpholinium terminal
group
3. dendrimer mk016, which is labelled DG, has piperidinium terminal group
Generation G1 G2 G3
Repetitive Units 6 12 24
Overall, nine molecular systems have been prepared: for all dendrimers 3 generations
have been considered, discriminated by the growing number of their repetitive units.
Each one of them has been put in complex with siRNA; the complexes were created
by placing dendrimers in close proximity of siRNA at 2 nm of distance (considering
their Center of Mass as reference). The obtained systems were again solvated in a
periodic box of 12 × 12 × 12 nm with a solute containing TIP3P water molecules and
the proper amount of Na+ and Cl- ions useful for system neutralization was added:
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(a) (b)
Figure 5.1: Molecular models representation of siRNA (a) and DP dendrimer (G3, b) used for
simulations (images taken from VMD). To clarify siRNA uraciles are colored in red,
guanines in cyan, cytosines in pink and adenine in yellow, while the phosphores are
represented as blue balls. Within G3 dendrimer, the central residue (CORE) is colored
in red, the repetitive (REP) branch units in cyan and the surface terminal groups are
represented in yellow.
it reproduces the 150 mM ionic concentration. An example of the model is shown in
Fig. 5.2 and the main characteristics of the simulated systems are summarized in the
Table 5.1.
5.2.3 Molecular Dynamics Simulations
Here molecular dynamics (MD) is used to investigate the local mechanism of binding
between siRNA molecules and different cationic dendrimers, providing informations
about the structural conformations and binding behavior [70], [97]. Thus, the molecu-
lar dynamics simulations take fully into account the siRNA flexibility together with
the presence of explicit solvent and ions.
Before starting with the MD simulations, all the molecular systems were minimized
and then equilibrated at 300 K by 200 ps molecular dynamics in the canonical NVT
ensemble. This stage was followed by two steps of density equilibration run (each
one of 200 ps) under NPT conditions with explicit solvent and pressure set to 1 bar
to obtain a reliable equilibrated configuration. Finally, the production dynamic lasted
for 50 ns has been performed under periodic boundary condition at 300 K and 1 atm
using the Langevin thermostat, and 10 angstrom for the cutoff value. The neighbour
list of 1.1 nm length was updated using the Verlet neighbour search algorithm every
50 time-steps.
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Figure 5.2: Snapshot of siRNA and DP dendrimer (G3) models in a box of 12×12×12 nm for
molecular dynamics simulations. Water molecules are omitted for clarity. Cl- and Na+
are colored in yellow and red respectively and represented as dots.
Every complex system was simulated using Gromacs-5 [78], a molecular dynamics
package designed for biomolecular systems exploited also for dendrimer systems
in the previous Chapter. To treat long-range electrostatic effects, the particle mesh
Ewald (PME) approach has been adopted [98] and the SHAKE algorithm was used
to constrain all bonds involving hydrogen atoms [99].
For parametrization of dendrimeric structures, as explained in Chapter 3, the cal-
culation method of Antechamber [100], module of AMBER 16, has been used: it
assigns parameters and force field types that are consistent with the General Amber
Force Field (GAFF) [101]. Consequentely, GAFF and TIP3P model [102] have been
employed for dendrimers and water molecules, respectively. All the images derived
from the MD simulations have been visualized by the VMD software [93].
5.2.4 Analysis
Since all dendrimer systems have been already evaluated previously (see Chapter
3), before studying complex systems, an accurate analysis on the siRNA has been
performed. In details, the evaluation over time of principal system parameters, as
Radius of Gyration (Rg) and Solvent-Accessible Surface Area (SASA) have been
executed.
Then, after the siRNA-dendrimer complex development and the trajectories analysis,
in order to identify the equilibrium states of every system, a conformational stability
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System Dendrimer siRNA Number of Na+ Number of Total number
charge charge and Cl- atoms water molecules of atoms
siRNA-DP G1 +12 -50 222 85371 87592
siRNA-DP G2 +24 -50 284 109848 112647
siRNA-DP G3 +48 -50 338 124941 128826
siRNA-DM G1 +12 -50 222 85395 87628
siRNA-DM G2 +24 -50 284 109887 112710
siRNA-DM G3 +48 -50 338 124932 128865
siRNA-DG G1 +12 -50 222 85374 87631
siRNA-DG G2 +24 -50 284 109830 112701
siRNA-DG G3 +48 -50 338 124719 128748
Table 5.1: Main features of the molecular systems simulated in this work.
estimation has been done, in terms of time evolution of RMSD as good indicator of
convergence of the structures.
Equilibrium Quantitative Analysis of siRNA-dendrimer Complex
With the purpose of studying the equilibrium conformations of all complex, cluster
analysis was performed, following the same steps of the only dendrimer systems
presented in the previous Chapter. In the average-linkage method, the cluster
similarity is assessed by computing the mean distance between members of each
cluster, where the distance between structures is given by the Root Mean Square
Deviation (RMSD) of the atomic positions after optimal superposition. Each system
snapshot was considered as part of a cluster when its distance to any element of the
cluster was less than a critical threshold.
After obtaining the equilibrium configurations, a quantitative analysis of the systems
in terms of Radius of Gyration (Rg), Solvent Accessible Surface Area (SASA), Buried
Surface Area (BSA), Root Mean Square Fluctuation, Contact Probability and Radial
Distribution Function has been performed. In details, with the aim of describing
the conformational modifications of every dendrimer and siRNA upon binding, the
values of the Radius of Gyration of the dendrimer within the complex (Rgden), of the
siRNA within the complex (Rgrna), of the dendrimer terminal groups (Rgter) and of
the whole complex (Rgcomplex) have been calculated over the equilibrium simulation.
Rg is not a true measurement of radius, but is defined as the root-mean-square
distance between each atom and the center of mass of the structure considered; it
gives important informations on the geometrical structure of the systems under
investigation:
R2g =
1
N
N
∑
k=1
(rk − rmean)
2 (5.3)
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Another molecular issue, derived from the data collected for the analysis, is the
so-called molecular Solvent-Accessible Surface Area (SASA), which describes the area
over which contact between solute and solvent can occur. The estimation of accessible
area calculation has been used to determine the Buried Surface Area (BSA). This
measurement was calculated to evaluate the relevant contact area between siRNA
and all dendrimer during the binding complex. Otherwise, concerning the study of
siRNA interaction with polycation dendrimers and with the purpose of quantifying
its flexibility, the root-mean-square fluctuation (RMSF) of siRNA sequence has been
calculated and it is defined as:
RMSF =
1
N ∑
i
√
√
√
√
1
T
T
∑
t=1
(ri(t)− < r >i)2 (5.4)
Moreover the Contact Probability between siRNA atoms and dendrimer ones has been
computed in order to elucidate the effect of dendrimer conformational properties
and its molecular geometry on the complex.
The contact probability for each siRNA base pair has been calculated using the
following procedure [103]. Trajectory snapshots are extracted from 50 ns of each
MD simulation, for each one the distance between a base pair in siRNA and all
residues of the interfacing dendrimer is calculated. If at least one distance value
among the residue-residue distances is under a chosen threshold (0.28 nm), the base
is considered in contact with the interfacing dendrimer in that snapshot. The number
of contact snapshots divided by the number of total snapshots taken out from the
MD trajectories is the contact probability associated with the siRNA residue.
Furthermore, with the aim of exploring the effect of siRNA binding on the distribution
of dendrimer atoms, several measurements of Radial Distribution Function (RDF)
have been computed for all the systems of interest.
The Radial Distribution Function or pair correlation function gAB(r) between particles
of type A and B is defined as:
gAB(r) =
< ρB(r) >
< ρB >local
=
1
< ρB >local
1
NA
NA
∑
i∈A
NB
∑
j∈B
δ(rij − r)
4πr2
(5.5)
with < ρB(r) > the particle density of type B at a distance r around particles A, and
< ρB >local the particle density of type B averaged over all spheres around particles
A with radius rmax, usually half of the box length.
Energetic Analysis
As made also for dendrimer systems (Chapter 3), the APBS package [94] was used to
compute the electrostatic potentials, by applying the linearized Poisson-Boltzmann
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equation using single Debye-Huckel sphere boundary condition on a 65×65×65 grid
with a spacing of 1 angstrom centered at the COM of the molecular system.
The dielectric constants of the solute and the solvent were set to 4 and 80, respec-
tively [104], [105]. In addition, the MM-PBSA Method has been used to calculate
binding energies of siRNA-dendrimer complexes. Specifically, this method gives
the different components of energy, in terms of MM (Molecular Mechanics), PB
(Poisson-Boltzmann) and SA (Surface Area) energy values. Its goal consists of inte-
grating high-throughput molecular dynamics (MD) simulations with binding energy
calculations. The tool also allows to obtain the residue wise energetic contribution to
total binding energy using energy decomposition scheme, which provides important
informations about contributing residues to siRNA-dendrimer association. In particu-
lar, gmmpbsa [106] is a tool that has been developed to enable the use of the MM-PBSA
method in conjunction with the GROMACS package. In general terms, the binding
free energy of a dendrimer with siRNA in solvent can be expressed as
∆Gbinding = Gcomplex − (Gdendrimer + GsiRNA) (5.6)
where, Gcomplex is the total free energy of the siRNA-dendrimer complex and Gdendrimer
and GsiRNA are total free energies of the isolated macromolecule and nucleic acid in
solvent, respectively. Furthermore, the free energy for each individual entity can be
given by
Gx =< EMM > −TS+ < Gsolvation > (5.7)
where x is the dendrimer or siRNA or the complex. < EMM > is the average molecular
mechanics potential energy in a vacuum. TS refers to the entropic contribution to
the free energy in a vacuum where T and S denote the temperature and entropy,
respectively. The last term < Gsolvation > is the free energy of solvation, which is the
energy required to transfer a solute from vacuum into the solvent. The potential
energy EMM includes the energy of both bonded as well as nonbonded interactions,
and it is calculated based on the molecular mechanics (MM) force-field parameters, as
described in Chapter 2. In the MM-PBSA approach, it is calculated using an implicit
solvent model. The solvation free energy is expressed as the following two terms
Gsolvation = Gpolar + Gnonpolar (5.8)
where Gpolar and Gnonpolar are the electrostatic and nonelectrostatic contributions to
the solvation free energy, respectively. The electrostatic term is estimated by solving
the Poisson Boltzmann (PB) equation, which is a second order nonlinear elliptic
partial differential equation, given by
∇[ǫ(r)∇ϕ(r)]− ǫ(r)κ(r)2sinh[ϕ(r)] +
4πρ(r)
kT
= 0 (5.9)
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where φ(r) is electrostatic potential, ǫ(r) is the dielectric constant and ρ(r) is the fixed
charge density. κ2 is related to the reciprocal of Debye length which is dependent
on the ionic strength of the solution. Unfortunately, this method does not take
into account the entropic term and therefore in principle is unable to give the
absolute binding energy; the tool is useful for calculating relative binding energies,
decomposing energy contributions on a per residue basis.
5.3 Results
5.3.1 Conformational Stability Analysis
SiRNA System Analysis
For a first check of the stability of siRNA structure, a conformational analysis was
performed: here results for the time evolution of Solvent Accessible Surface Area and
Radius of Gyration for 100 ns of MD simulation are reported (Fig. 5.3).
In particular, a stable value around 97 nm2 of SASA is shown by simulation data,
thus, concerning the trend of Rg over time, after a little reorganization there are not
visible variations of the value that reaches almost to the beginning of the simulation
2.4 nm. The resulting data are synthesized in the Table 5.2, in which the hydrophobic
and the hydrophilic components of the SASA are distinguished and for which the
second is greater and predominant with a calculated value of ∼ 72.09 percentage
of the total. From the measurements obtained of Rg and SASA over time it follows
that siRNA system is stabilized and it can be used together with every dendrimer
model already prepared in order to build the complex systems, which are the topic
of interest in this thesis work.
(a) (b)
Figure 5.3: Time evolution of Radius of Gyration (left) and Solvent Accessible Surface Area (right)
for siRNA over 100 ns of MD simulation.
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Rg Total SASA Hydrophobic component Hydrophobic component
(nm) (nm2) (% of total) (% of total)
2.40 ± 0.1 97.63 ± 1.07 27.91 ± 1.3 72.09 ± 1.4
Table 5.2: Radius of Gyration (left) and Solvent Accessible Surface Area components (right) as a
percentage of total (average value and standard deviation) for equilibrated siRNA.
Complex System Analysis
Concerning with the complexation between siRNA and dendrimer, before conducting
an equilibrium investigation some conformational stability analysis has been per-
formed. Here is reported the time evolution of Root-Mean-Square Deviation (RMSD)
in order to evaluate the system stability during MD simulation.
The relative plots are presented in Fig. 5.4 for whole complex, distinguishing den-
drimer and siRNA RMSD. The RMSD data show that all the systems converge to
the equilibrium with good stability. Moreover, the plots highlight for all considered
components the parameter reach a plateau, showing a relative stable trend after ∼ 25
ns. It mainly happens for all siRNA-DG complex systems and siRNA-DP for G1 and
G2, differently for siRNA-DM G2 and siRNA-DP G3 to whom the stability is reached
only after ∼35 ns of simulation, before which occurs a reorganization of the whole
structure.
These observations further confirm that complex systems such as presently studied
need more time to reach equilibrium compared to a simple one, as dendrimer systems
presented in the previous chapter that needed less stabilization time.
To evaluate the interaction area between siRNA and dendrimer along the simulation
time, their relative Buried Surface Area (BSA) has been studied. The results for the
three systems are plotted in Fig. 5.5, discriminating dendrimer generations.
From the pictures is evident that all the complexes were formed around 15 ns of
simulation; in details,all siRNA-G1 dendrimer reach a stable complex configuration
after just 5 ns.
Differently, the others (expecially DM-G3/G2 and DG-G3/G2) exhibit a longer fea-
ture with dendrimer and siRNA detached, until the time of binding after ∼ 15 ns of
simulation or later.
All other dendrimers fit with siRNA structure in a binding configuration in a very
short time, however the visible fluctuations in the graphs reflect the movement and
the adaptation of the two structure (siRNA and dendrimer) before the formation of a
stable complex.
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Figure 5.4: Time evolution of total Root-Mean-Square Deviation (RMSD) distinguishing the whole
complex, siRNA and dendrimer components, for all dendrimer generations: G1; G2; G3.
Figure 5.5: Time evolution of Buried Surface between siRNA and three types of dendrimers: DP (a);
DM (b); DG (c), distinguishing three generations.
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5.3.2 Equilibrium Quantitative Analysis of siRNA-dendrimer Complex
The Cluster Analysis has been used to find the best equilibrium configuration for the
complexes.
As done previously for unbound dendrimers, for each molecular system the center
of the most populated cluster has been considered as input for the equilibrium quan-
titative analysis and for electrostatic calculations of the siRNA-dendrimer complexes.
It represents more than 80% of the MD trajectory; the resulting snapshots of the
equilibrated siRNA-dendrimer complex configurations are reported in Fig. 5.6-5.8.
Figure 5.6: Equilibrium configuration of the binding between siRNA (red) and DP dendrimer, dis-
tinguishing dendrimers generations: G1 (a); G2 (b); G3 (c). Ions of dendrimer terminal
groups are highlighted in yellow.
In detail, in the pictures nucleic acids are represented as red ribbons and surface
amines that carry a one charge are represented as spheres coloured in yellow; the
core of dendrimer is highlighted with the red color and for clarity water and ions
are not shown. However, this specific representation of complex models helps to
better understand the differences between the siRNA binding modalities of globular
dendrimers (as generation 4) and flexible ones (lower generations). This behaviour
together with the different electrostatic interactions inside the complex will be inves-
tigate using APBS method.
The snapshots related to all G3 dendrimers highlight a significant decrease of siRNA
length during the MD simulation, caused by a winding around the dendrimer.
The reason here can be found in the presence of the terminal uracil in the nucleic
acid strand, which add flexibility and with its proximity to dendrimer can wrap itself
around it.
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Figure 5.7: Equilibrium configuration of the binding between siRNA (red) and DM dendrimer,
distinguishing dendrimers generations: G1 (a); G2 (b); G3 (c). Ions of dendrimer terminal
groups are highlighted in yellow.
Figure 5.8: Equilibrium configuration of the binding between siRNA (red) and DG dendrimer, dis-
tinguishing dendrimers generations: G1 (a); G2 (b); G3 (c). Ions of dendrimer terminal
groups are highlighted in yellow.
The results of quantitative analysis are here discussed in order to find remarkable
characteristics of every siRNA-dendrimer system under investigation.
During the binding to an oppositely charged macromolecule, the bases of siRNA
involve in the interaction undergo some alteration and become locally distorted to
accommodate the dendrimer moieties.
This involves in a local stretching of the phosphate backbone that alters and reduces
some degree of freedom at the binding zone[107].
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Figure 5.9: Representation of RMS fluctuations of siRNA base pairs within the complex.
RMS fluctuations of siRNA base pairs within the complex have been computed.
The structural flexibility of border bases of siRNA during the binding process is
confirmed by a significant raise in RMSF of border nucleotides of siRNA antisense
strand (Adenine and Guanine, as shown in Fig. 5.9).
The value of RMSF increases over 0.6 nm and it is directly related to a higher solvent
exposure after a partial siRNA opening.
The antisense strand is more exposed to dendrimer contact because of the presence of
four unpaired nucleotides, which are located at the two extremes (Adenine-Guanine
and Adenine-Uracil, respectively).
Moreover, in order to identify the nucleotides that are mainly responsible for siRNA-
dendrimer interaction by contact probability plots, for each system MD trajectory at
300 K was analysed. The siRNA residues contact probability to dendrimer has been
calculated, applying a distance cut-off of about 0.28 nm (roughly the diameter of a
water molecule).
SiRNA bases mainly responsible for complex interaction have been identified by
contact probability plots (Fig. 5.10-5.12).
As a result, analysing all systems specific residues most frequently involved in the
binding. Considering DP dendrimers, particularly, uracil and cytosine are the mostly
part of the contact area with over the 90% of siRNA contact probability, except for G2
which exhibit a value around 85%. Thus, comparing all different macromolecules,
nucleotides are strongly involved in the interaction with DP dendrimers, as demon-
strated by the high contact probability values.
Moreover, also in siRNA/DM-G2 and siRNA/DG-G3 interaction interface participate
primarily cytosines and uracils of sense and antisense strands, with high contact
probability around 90%.
Otherwise, lower contact probability values and lower number of nucleotides involv-
ing the interaction were detected in case of all siRNA-G1 dendrimers (and also G2),
which have weaker electrostatic attraction caused by fewer positively charged amine
groups available for the interaction.
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Figure 5.10: Nucleotides that are mainly responsible for siRNA-dendrimer interaction have been
identified by contact probability plots in case of DP, DM and DG generation one systems.
Figure 5.11: Nucleotides that are mainly responsible for siRNA-dendrimer interaction have been
identified by contact probability plots in case of DP, DM and DG generation two
systems.
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Figure 5.12: Nucleotides that are mainly responsible for siRNA-dendrimer interaction have been
identified by contact probability plots in case of DP, DM and DG generation three
systems.
Furthermore, we have analyzed the MD trajectories in order to characterize the
conformational changes of dendrimers upon binding.
Considering the flexibility/rigidity ratio as one of the five critical parameters (size,
shape, surface chemistry, flexibility/rigidity, and molecular geometry) [84], the value
of the Radius of Gyration of the whole complex and those of the dendrimer and
siRNA in binding condition has been evaluated for all equilibrated systems.
In fact, the level of reorganization in a specific structure is provided by these Rg
values.
The averages of Radius of Gyration obtained from the analysis are summarized
in Table 5.3 along with the relative standard deviations; we observe that with the
increase of generation grows the value of Rg due to the greater amine density and
branching units.
In the Fig. 5.13 are represented the average values and the error bars of Rg as func-
tion of dendrimer generation, comparing the case of siRNA and the three dendrimers
within the complex.
Particularly, siRNA Rg presents no significant variations between dendrimers gen-
erations and the value remains around 2.25 nm; differently, with the increase of
generation Rg of all three dendrimers grows from sim1 nm (for G1) to ∼ 2.35 nm
(with a maximum value of 2.47 for DG dendrimer).
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System Rg(nm) Complex Rg(nm) siRNA Rg(nm) Den Rg(nm) Ter
siRNA-16/CEF/051 G1 2.15 ± 0.04 2.12 ± 0.05 1.00 ± 0.12 1.20±0.03
siRNA-16/CEF/051 G2 2.32 ± 0.09 2.30 ± 0.05 1.40 ± 0.03 1.68±0.02
siRNA-16/CEF/051 G3 6.05 ± 0.21 2.24 ± 0.04 1.78 ± 0.05 2.09±0.03
siRNA-16/CEF/294 G1 2.27 ± 0.07 2.23 ± 0.04 1.02 ± 0.03 1.20±0.01
siRNA-16/CEF/294 G2 4.75 ± 0.26 2.28 ± 0.05 1.34 ± 0.03 1.58±0.02
siRNA-16/CEF/294 G3 7.48 ± 0.23 2.25 ± 0.05 1.80 ± 0.08 2.06±0.03
siRNA-mk016 G1 2.37 ± 0.06 2.31 ± 0.06 1.00 ± 0.03 1.15±0.02
siRNA-mk016 G2 2.13 ± 0.03 2.25 ± 0.04 1.42 ± 0.04 1.66±0.02
siRNA-mk016 G3 2.41 ± 0.05 2.24 ± 0.06 1.90 ± 0.03 2.23±0.02
Table 5.3: Average value and standard deviation of Radius of Gyration (Rg) of the Complex, as
composed by dendrimer and siRNA, of the single nucleic acid (siRNA), of the dendrimer
for different generations.
(a) (b)
Figure 5.13: Average value and error bar of Rg as a function of dendrimer generation. (a) Compar-
ison of Rg of all dendrimers; (b) comparison of Rg value for siRNA in complex with
dendrimers.
In addition, all Rg of dendrimers are characterized by small fluctuations, which
implies that they undergo very little deformation during the simulations. In the
binding process the biggest part of the siRNA double helix still remains outside the
dendrimer, and this reflects in the Rg of siRNA being larger than the dendrimer one.
Moreover, the siRNA is a duplex, and the base pairing/stacking interactions between
the opposite strands concur to confer an intrinsic rigidity to the overall structure,
preventing a substantial wrapping of the nucleic acid around the dendrimer surface.
The highest value of Rg is reached by the DM complex for which indeed is found a
particular dovetail between siRNA and dendrimer (as seen in relative snapshot above).
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Moreover, the different adaptability of smaller (G1) and biggest generations (G3) have
an impact on the dendrimer-siRNA complexes, thus the second ones present charged
amine terminal groups that electrostatically repulse to each other, contributing to
form a broader structure, judging by the values of radius of gyration.
Another interesting consideration concerns the changes in conformation of den-
drimers upon binding that can be assessed by comparing the Rg of the dendrimer
and of cationic end groups, the higher values of this second ones reflects the orien-
tation of external charged groups on the periphery toward the siRNA. The average
value of total SASA for siRNA is 97.96 nm2 with a hydrophobic percentage of 27.3 ±
1.3 and hydrophilic 72.7 ± 2.0 % of the total.
The values obtained for all dendrimers are not nearly different to the ones related to
only dendrimers system and show a prevalence of hydrophobic component, with a
percentage around 88 for DP and DG and around 82 for DM dendrimers. Below in
Fig. 5.14 are reported the average values and relative error bars, comparing dendrimer
and siRNA SASA components.
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(a)
(b)
(c)
Figure 5.14: Histograms of average values, comparing dendrimer and siRNA SASA components.
The Rg considerations are also supported by the analysis of the solvent-accessible
surface area SASA, for which histograms that distinguish hydrophobic and hy-
drophilic component for dendrimers and for siRNA have been reported within
the complex. From results, it is highlighted the prevailing hydrophobic and the
hydrophilic components of dendrimer and acid nucleic, respectively. In details,
comparing the values with the ones founded in the previous chapter for unbounded
dendrimers, there are no significant variations in the SASA of dendrimers in complex
with siRNA. The highest percentage of hydrophilic component (around 18 % of total
SASA) for the dendrimer remains evident in compared to others, due to atomic
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constitution of morpholinium (terminal groups), with a maximum average value of
19.4 % for DM-G2 dendrimer.
Moreover, the RDF profiles calculated over equilibrium configurations suggest how
the structures may behave in space over time.
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Figure 5.15: Equilibrium Radial Distribution Function (RDF) of dendrimer in reference to siRNA for
all generations of three dendrimers: DP (a); DM (b); DG (c).
On one hand, in the RDF plots sharp peaks correspond to a large number of atoms
confined both spatially and temporally, on the other hand large features correspond
to less confined, rapidly reorganizing domains.
Concerning the RDF of whole dendrimer in reference to siRNA (Fig. 5.15), the
radial distance over which density remains almost constant increases with increasing
dendrimer generation. For high generation dendrimers (G3), there is a constant
density zone from 1 to 3.5 nm of distance, signifying the compact nature of the higher
generation dendrimer. This may be a consequence of the higher level of extended
branches on the dendrimer as observed in the simulation snapshots of the dendrimers
and it provides informations about the spatial arrangement of the terminal groups.
Otherwise, for lower dendrimer generations a region of high density is visible near
the phosphates of siRNA, since the branches are not spread out. In each case, the
density shows a maximum and the overall density decays more gradually. The peak
of the radial distribution function shifts with the increase in generation and the result
is that the higher generation dendrimers are more rigid when compared to the lower
generation dendrimer. This phenomenon is accentuated by the electrostatic repulsion
between a higher number of terminal groups.
The non-uniformity in peak height in the RDF profile suggests a difference in the
ability of the two regions to readily vibrate. The rigid core region is forbidden from
free vibrations in comparison to the oscillations that occur at the terminal groups
of the dendrimer. In general, each layer of surface groups added to the further
generation tends to saturate the surface of the dendrimer, meaning the molecule is
less able to orient its active groups toward the target to optimize the interactions and
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the efficiency of the scaffold to use each surface group decreases, it results in a switch
from flexible to rigid behaviour of dendrimers in the binding with siRNA.
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Figure 5.16: Equilibrium Radial Distribution Function (RDF) of amine groups around O1P and O2P
siRNA atoms for all generations of three dendrimers: DP (a); DM (b); DG (c). Only
charged amine groups are considered for the calculation.
In addition, the equilibrium RDF of amine groups around O1P and O2P siRNA
atoms has been studied in order to investigate the nature of the interactions between
protonated amine groups and siRNA phosphate group oxygen atoms, as done in
previous works [108], and the results are shown in Fig. 5.16.
The pictures are characterized by two different peaks at 2.7 and 4.3 angstrom, in
agreement with previous computational observations [109]. Importantly, the first
peak assesses the primary interaction resulting from the hydrogen bond between the
amine hydrogen atoms and the phosphate oxygen, while the second peak is related to
the water-mediated hydrogen bonding. In the Table 5.4 the average number of amine
groups of each dendrimer for different generations, interacting with siRNA O1P and
O2P atoms averaged over the last 20 ns of each Molecular Dynamics trajectory at
300 K has been reported. It shows the percentage of amine groups that participate
in the interaction with oxygen and phosphate atoms of siRNA. Furthermore, the
principal differences observed in terms of peak heights have been calculated by the
measurement of contacts between the amine nitrogen atoms involved in primary
or secondary interactions with the phosphate oxygens over the last 20 ns of MD
trajectory at 300 K.
For an integral analysis of interactions within the complex, the RDF of charged amine
groups around electronegative atoms in siRNA grooves has been developed (Fig.
5.17).
In details, G1-dendrimers are able to interact with a high number of phosphate
groups through their amine groups, following by G2 ones. It is due to the flexible
nature of their structures and it’s a crucial point because these dendrimers exhibit
the alignment of their backbone with the siRNA phosphate groups in the major
grooves. Otherwise, the flexibility loss moving to higher generations and it follow
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System Total amines groups Primary % Secondary % % Total Amines
siRNA-16/CEF/051 G1 12 83 17 100
siRNA-16/CEF/051 G2 24 54 4 58
siRNA-16/CEF/051 G3 48 50 15 65
siRNA-16/CEF/294 G1 12 75 8 83
siRNA-16/CEF/294 G2 24 46 13 59
siRNA-16/CEF/294 G3 48 35 10 45
siRNA-mk016 G1 12 67 8 75
siRNA-mk016 G2 24 71 12 83
siRNA-mk016 G3 48 23 13 36
Table 5.4: Average number of amine groups of each dendrimer for different generations, interacting
with siRNA O1P and O2P atoms averaged over the last 20 ns of each Molecular Dynamics
trajectory at 300 K.
that dendrimers are not capable so well to align with the siRNA’s phosphate groups.
DP dendrimers show the best ability of aligning with siRNA backbone (except for
DP-G2), with high values of amine groups interacting with siRNA (100 % of total for
DP-G1).
Moreover, also amine groups of DP-G3 despite their stiffness, interact with the
electronegative atoms in the siRNA backbone with average values of 65 and 38 % of
total (Table 5.5). It is evident that the terminal groups of the first three generations
of dendrimers present high spatially connected with the siRNA structure, for which
the majority of distribution state at a distance lower than 2 nm; with the increase of
generation the spatial density changes.
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Figure 5.17: Equilibrium Radial Distribution Function (RDF) of amine groups around electronegative
atoms in siRNA grooves for three dendrimers for all generations of three dendrimers:
DP (a); DM (b); DG (c). Only charged amine groups are considered for the calculation.
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System Total amines groups Primary % Secondary % % Total Amines
siRNA-16/CEF/051 G1 12 17 8 25
siRNA-16/CEF/051 G2 24 8 17 25
siRNA-16/CEF/051 G3 48 8 15 23
siRNA-16/CEF/294 G1 12 8 17 25
siRNA-16/CEF/294 G2 24 12 13 25
siRNA-16/CEF/294 G3 48 4 12 16
siRNA-mk016 G1 12 25 25 50
siRNA-mk016 G2 24 13 17 30
siRNA-mk016 G3 48 4 6 10
Table 5.5: Average number of amine groups of each dendrimer for different generations, interacting
with electronegative atoms in siRNA grooves averaged over the last 20 ns of each Molecular
Dynamics trajectory at 300 K.
Equilibrium Evaluation of Charges Effect
The equilibrium binding conformations were analysed to describe the electrostatic
potential of the resulting complex. Particularly, the electrostatic potentials were
computed using the APBS package, by applying the Poisson-Boltzmann equation. The
resulting configurations are reported below. The siRNA structure together with the
representation of charge distribution and the map of electrostatic interactions founded
using Adaptive Poisson-Boltzmann Solver (APBS) method, showing prevalence of
negative net charges on the surface of siRNA (Fig. 5.18).
Figure 5.18: SiRNA representations: the equilibrated structure (left). Map of electrostatics interac-
tions founded using Adaptive Poisson-Boltzmann Solver (APBS) method for siRNA
(right, snapshot of the simulation after cluster analysis).
An accurate investigation of the electrostatic map leads to find different typologies
77
of binding regions (results are presented in Fig. 5.19-5.21).
Firstly, the negative electrostatic potential of the siRNA is visible in all the complexes.
For dendrimers of high generation only a limited part of the charged surface groups
interacts actively with siRNA while a larger part of charged amines is back folded.
On the other hand, dendrimers of lower generations (flexible), appear to exert both
electrostatic and hydrophobic interaction with the siRNA.
This phenomenon leads to formation of merged complexes that appear to be a single
neutralized or barely charged entity; it is emphasized for dendrimers of G1 and G2
where the neutralization at the binding of siRNA and dendrimer is visible as a white
color in the APBS map. Thus, all dendrimers of first and second generation are able
to neutralize the siRNA.
Otherwise, all dendrimers of third generation behave as rigid systems in binding
with siRNA leading to complexes of charged patches, as shown in figure where they
exhibit a positive net charge and are surrounded by a positive potential, while a
negative net charge extends on nucleic acid. This positive potential may allow the
formation of multivalent interactions with other siRNA molecules.
Finally, dendrimers of third generation (and also DM-G2) show an intermediate bind-
ing behaviour with siRNA, because is both affected by hydrophobic and electrostatic
forces which are distributed over a larger and more rigid molecule.
Figure 5.19: Map of electrostatics interactions founded using Adaptive Poisson-Boltzmann Solver
(APBS) method, for generation one of all dendrimers (snapshot of the simulation after
cluster analysis): DP (a); DM (b); DG (c).
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Figure 5.20: Map of electrostatics interactions founded using Adaptive Poisson-Boltzmann Solver
(APBS) method, for generation two of all dendrimers (snapshot of the simulation after
cluster analysis): DP (a); DM (b); DG (c).
Figure 5.21: Map of electrostatics interactions founded using Adaptive Poisson-Boltzmann Solver
(APBS) method, for generation three of all dendrimers (snapshot of the simulation after
cluster analysis): DP (a); DM (b); DG (c).
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Binding Energy Evaluation
To calculate the average binding energy and the associated confidence intervals, a
bootstrap analysis was performed, using ggm pbsa tool.
By decomposing the total dendrimer/nucleic acid interaction energy for each binding
residue, we were able to point the attention on those residues that actively participate
to the binding.
In order to obtain the average contribution of all residues (of dendrimer and siRNA)
to the binding energy, it was used a python script.
Below are plotted the energetic contribution of single residues of the complex (Fig.
5.22-5.24).
All the plots reported the first 50 residues, as shown in the pictures, belonging to
siRNA, thay are separated from the dendrimer residues by a red line. Clearly, with
the increase of dendrimer generation grows also the number of residues.
From pictures is visible that the principal dendrimer energetic contribution comes
from terminal groups of dendrimer, highlighted by a colored square, otherwise core
and other internal branches do not make significant contribution.
For complex with dendrimers of first and second generation, the contribution is given
primarily by all terminal groups of dendrimers, denoting their flexible behaviour and
the high binding nature that their form with siRNA.
Differently, with the increase of generation (and also the number of peripheral units),
not all terminal groups participate in binding and the energetic contribution of siRNA
is almost of the same order then the dendrimer one.
As has already been observed by related snapshots, for DP-G3 dendrimer the con-
tribution comes from a large number of terminal groups and evenly from all the
siRNA strands, it reflects the different binding conformation which is formed for this
complex.
In addition, to calculate average binding energy, a python script has been used
and here are reported the resulting average and standard deviation values of all
energetic components including the binding energy for all different dendrimers.
The Tables 5.6-5.8 below contain average values and standard deviations for all the
systems (compared for different dendrimer generation).
The energetic contributions consider Van der Waals, Electrostatic, Polar Solvation,
Sasa apolar component and binding energy.
Because of the limits of ggm pbsa tool [106], this energy calculation does not take into
account the entropy term, which is fundamental to a correct estimate of free energy.
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Figure 5.22: Contribution of residues to the binding energy found with MM-PBSA method, for all
dendrimer: G1.
81
Figure 5.23: Contribution of residues to the binding energy found with MM-PBSA method, for all
dendrimer: G2.
82
Figure 5.24: Contribution of residues to the binding energy found with MM-PBSA method, for all
dendrimer: G3.
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Energy Components siRNA-DP siRNA-DP siRNA-DP
(kJ/mol) G1 G2 G3
Van der Waals -394.15±42.6 -428.73±51.6 -965.94±58.1
Electrostatic -10218.96±207.3 -15602.62±440.6 -33122.32±118.9
Polar Solvation 2522.70±182.2 2755.50±302.4 6177.66±234.1
SASA -41.69±3.4 -45.99±4.5 -92.90±2.9
Binding -8132.11± 187.4 -13321.84±416.0 -28003.50±54.2
Table 5.6: Average and standard deviation of all Energetic Components for siRNA − DP complex.
Energy Components siRNA-DM siRNA-DM siRNA-DM
(kJ/mol) G1 G2 G3
Van der Waals -385.90±47.3 -688.83±18.3 -1113.24±14.9
Electrostatic -9895.50±213.2 -16807.93±136.6 -32292.32±82.4
Polar Solvation 2351.55±270.0 4040.18±61.0 6059.15±28.1
SASA -41.61±3.9 -67.83±0.2 -98.66±2.5
Binding -7971.46± 118.2 -13524.42±57.0 -27445.07±122.9
Table 5.7: Average and standard deviation of all Energetic Components for siRNA − DM complex.
Energy Components siRNA-DG siRNA-DG siRNA-DG
(kJ/mol) G1 G2 G3
Van der Waals -357.22±45.0 -543.42±115.0 -648.55±132.1
Electrostatic -8643.93±198.3 -17794.19±597.9 -25777.22±2133.1
Polar Solvation 2092.98±265.2 2970.64±494.9 2696.56±592.0
SASA -39.49±3.8 -55.83±10.3 -62.10±10.2
Binding -6947± 141.2 -15422.80±289.8 -23791.31±170.3
Table 5.8: Average and standard deviation of all Energetic Components for siRNA − DG complex.
(a) (b) (c)
Figure 5.25: Histograms of electrostatic contribution and binding energy of siRNA-dendrimers
systems: DP (a); DM (b); DG (c).
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Figure 5.26: Histograms of electrostatic contribution and binding energy of siRNA-dendrimers
systems: G1 (a); G2 (b); G3 (c).
In addition, the histograms in Fig. 5.25 report the percentage values of electro-
static average contribution and binding energy between different generations of the
same dendrimer. It highlights that both the values grows with generation, thanks to
the presence of a growing number of charges atoms interacting. Otherwise, the his-
tograms in Fig. 5.25 report the percentage values of electrostatic average contribution
and binding energy between same generations of different dendrimers. SiRNA-DP
complexes exhibit higher values for G1 and G3, while for G2 siRNA-DG seems to be
the complex with the maximum electrostatic and binding contributions.
5.4 Discussion
Owing to several possible applications in gene therapy, the development of molecular
systems composed of nucleic acids and macromolecules catches attention in current
scientific research. Moreover, the delivery of genetic materials into cells represents
a great solution for therapeutic purposes. Among all possible molecule designs
devoted to interact with nucleic acids, here the focus is put on the siRNA-dendrimer
complex formation at atomistic level.
Molecular dynamics has been used to evaluate interactions between the nucleic
acid and the macromolecules along the complex building. In details, 50 ns of
MD simulations in the water environment have been carried out for nine siRNA-
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dendrimer systems. Here most likely interacting sites were identified, thanks to the
description of siRNA and dendrimer conformational changes due to the binding
process. From the inspection of all systems emerge a significant information. It
is the difference between terminal groups that leads to quantifiable variations in
the energetic of binding as well as different conformational responses within the
complexes [80]. From the analysis the siRNA-dendrimer complexation seems to be a
multi-step process with an initial fast electrostatic binding, mainly driven by charged
atoms, followed by slower structural global rearrangements. Our results suggest that
DP dendrimers manifest highest binding efficacy.
Moreover, the equilibrium binding conformations have been further investigated to
evaluate the electrostatic potential and the charge neutralization mechanisms of the
siRNA-dendrimer complex. In particular, data highlight the predominant siRNA-
dendrimer interaction between the electronegative phosphates present on siRNA
backbone and charged amines of dendrimer terminal groups. In addition, the MD
simulations also show siRNA groove binding of the dendrimers.
Furthermore, quantitative examination of the electrostatic contribution suggests
interesting differences in the dendrimer binding regions. While G1 and G2 were
able to neutralize the siRNA electrostatic potential in the binding region, all G3 were
surrounded by a positive potential, which may allow the formation of multivalent
interactions with other siRNA molecules. This phenomenon may become significant
for larger generation dendrimers, which reveal more compact and rigid configurations.
All G1 and G2 dendrimers exhibit the ability to use their surface residues more
uniformly, avoiding preferential binding spots into the binding site. This leads to a
uniform vibrational behaviour of N and P charged atoms of dendrimer and siRNA
and thus in a stable binding for these complexes.
The analysis also show that cytosine and uracil of siRNA play a dominant role in
the siRNA-dendrimer contact surface, especially in case of DP dendrimer, wherein
nucleotides exhibit high values of contact probability. The results of siRNA-dendrimer
contact probability have been compared to residues contribution on electrostatic
potential for the equilibrium binding conformations, showing the dominant role of
ions of dendrimer terminal groups in the binding process.
Moreover, for a complete analysis of interactions within the complex, the radial
distribution function of charged amine groups around electronegative atoms in
siRNA grooves has been developed. In details, all G1-dendrimers are able to interact
with a high number of phosphate groups through their amine groups, also G2 ones
show similar behaviour. It may be due to the flexible nature of their structures and it
represents a crucial point because these dendrimers exhibit the alignment of their
backbone with the siRNA phosphate groups in the major grooves. Differently, a
loss of flexibility moving to higher generations has been reported and it follows that
dendrimers are not capable so well to align with the siRNA’s phosphate groups.
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From results DP dendrimers show the best ability of aligning with siRNA backbone
(except for DP-G2), with high values of amine groups interacting with siRNA (100 %
of total for DP-G1). Also amine groups of DP-G3, despite their stiffness, interact with
the electronegative atoms in the siRNA backbone.
Moreover, in order to identify the nucleotides that are mainly responsible for siRNA-
dendrimer interaction, MD trajectory at 300 K was analysed for each system. The
siRNA residues contact probability with dendrimer has been calculated, applying
a distance cut-off of about 0.28 nm (roughly the diameter of a water molecule).
SiRNA bases mainly responsible for complex interaction have been identified by
contact probability plots. As a result, all systems have been analysed with the aim of
locating specific residues that most frequently involve in the binding. Considering
DP dendrimers, particularly, uracil and cytosine nucleotides cover the mostly part of
the contact area with over the 90% of siRNA contact probability, whereas G2 exhibits
a value around 85%. Thus, comparing all different macromolecules, nucleotides are
strongly involved in the interaction with DP dendrimers, as demonstrated by the
high contact probability values. Moreover, also in siRNA/DM-G2 and siRNA/DG-G3
interaction interface participate primarily cytosines and uracils of siRNA, with high
contact probability around 90%. Otherwise, lower contact probability values and
lower number of nucleotides involving the interaction were detected in case of all
siRNA-G1 dendrimers, which have weaker electrostatic attraction caused by fewer
positively charged amine groups available for the interaction.
5.5 Conclusion
We wanted to evaluate the characteristics of three different types of dendrimers (DP,
DM and DG) in complex with a model of siRNA in order to study the structural and
electrostatic behaviour in the binding condition. With the support of MD simulations
we obtained several important informations about the peculiarity of the complexes,
which show to be dependent on size, conformation, or surface properties of both
dendrimer and nucleic acid. The analysis shows good binding configurations in case
of complex between siRNA and DP dendrimers. The work presented here provides
great insights into the complexation mechanism, elucidating how binding modes are
influenced by the physico-chemical properties of different interacting dendrimers.
Thus, these analysis could be useful for further investigations on interaction to
assist the design/development of potent and selective RNA drug carrier systems
and to achieve the best compromise between complexation stability and release
ability. Furthermore, these results may advantage the evaluation of treatment of lung
inflammation with gene therapy and other several applications in nanomedicine. In
fact the development of highly-efficient macromolecules as good carriers will allow
advances in understanding of interactions involved in the gene deliver process.
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Chapter 6
Conclusions And Future
Perspective
In summary, considering the safety issues and other drawbacks of viral approach, the
nonviral vectors for siRNA delivery are increasingly concerned as the alternatives of
viral ones. Among versatile non-viral vectors, dendrimers have been shown excellent
characteristics as nanocarrier in gene therapy, therefore the small interfering RNA
(siRNA) targeting tumor necrosis factor alpha (TNF-alfa) was used in complex with
dendrimers for gene silencing in COPD treatment.
In the last years significant researches have been carried out to develop dendrimer-
based nanomedicine for the delivery of drugs and nucleic acids. A detailed quantita-
tive analysis of the physical interactions between dendrimers and bioactive agents or
biomolecules is a crucial step in understanding the delivery mechanisms.
In this connection, computational molecular methods represent a powerful tool to
provide quantitative and dynamic informations in order to determine ligands mecha-
nism of action and differences in their therapeutic potential. This work presents a
molecular dynamics method to study the complex of three types of functionalized
dendrimers to siRNA at 150 mM salt concentration.
In this thesis the attention is focused on the investigation of different complexa-
tion between the funzionalized nanocarriers and siRNA on the atomic scale. With
the purpose of investigating the effect of molecular geometry, dendrimer flexibility
and charge density, three dendrimers configurations have been considered for the
calculation: 16/CEF/051, 16/CEF/294 and mk016 with growing repeating units, cor-
responding to 3 different generations. We found that the positively charged surface
of dendrimers induces not only increased cellular uptake through charge mediated
interactions. Moreover, the data show a higher efficacy in term of siRNA-dendrimer
binding for 16/CEF/051 and 16/CEF/294, which present pyrolidinium or piper-
azinium surface groups, respectively. Whereas morpholidinium terminals lead to a
lower effect, especially in case dendrimers of generation 3.
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Moreover, the influence of macromolecules architecture on the rigid and flexible
behaviour in binding siRNA has been studied, recognizing the role of dendrimer
generation on the complex composition.
The thesis does not pretend to be an exhaustive overview but elucidates main pas-
sages of the siRNA-dendrimer complexation at nanoscale level by MD simulations. It
provides new contributions into the definition of flexibility properties and puts the
attention on binding efficiency, suggesting new paradigms in the design of molecules
devoted to interact with nucleic acids.
Further investigations are needed in order to better characterize the free energy land-
scape. In this regard, an interesting avenue for future computational studies could be
the use of enhanced sampling computational methods, like umbrella sampling and
metadynamics, which are very powerful tools able to elucidate the energetic reasons
behind binding mechanisms.
These informations may be relevant to better understand ligand mechanism of action
and peculiarities in their therapeutic potential and may open the prospective of
dendrimer-base practical production for siRNA delivery in the future.
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